WO1997045547A2 - Localised cell death in plants - Google Patents

Localised cell death in plants Download PDF

Info

Publication number
WO1997045547A2
WO1997045547A2 PCT/EP1997/002749 EP9702749W WO9745547A2 WO 1997045547 A2 WO1997045547 A2 WO 1997045547A2 EP 9702749 W EP9702749 W EP 9702749W WO 9745547 A2 WO9745547 A2 WO 9745547A2
Authority
WO
WIPO (PCT)
Prior art keywords
nucleic acid
plants
plant
acid molecule
acid sequence
Prior art date
Application number
PCT/EP1997/002749
Other languages
German (de)
French (fr)
Other versions
WO1997045547A3 (en
Inventor
Lothar Willmitzer
Bernd Müller-Röber
Original Assignee
MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. filed Critical MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V.
Priority to AU31684/97A priority Critical patent/AU3168497A/en
Publication of WO1997045547A2 publication Critical patent/WO1997045547A2/en
Publication of WO1997045547A3 publication Critical patent/WO1997045547A3/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • C12N9/2408Glucanases acting on alpha -1,4-glucosidic bonds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8262Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield involving plant development
    • C12N15/8263Ablation; Apoptosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8271Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance
    • C12N15/8279Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for stress resistance, e.g. heavy metal resistance for biotic stress resistance, pathogen resistance, disease resistance
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8261Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield
    • C12N15/8287Phenotypically and genetically modified plants via recombinant DNA technology with agronomic (input) traits, e.g. crop yield for fertility modification, e.g. apomixis
    • C12N15/8289Male sterility
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1048Glycosyltransferases (2.4)
    • C12N9/1051Hexosyltransferases (2.4.1)
    • C12N9/1055Levansucrase (2.4.1.10)

Definitions

  • the present invention relates to nucleic acid molecules which, when expressed in plants, lead to the production of localized cell death, and to plant cells and plants which contain such nucleic acid molecules.
  • Plants are attacked by various pathogens throughout.
  • a particular problem with regard to the attack of plants by pathogens arises in the current form of agriculture, which is characterized in that, due to the large-scale cultivation of monocultures, resistance introduced by means of breeding methods is overcome relatively quickly by mutations on the part of the pests.
  • the vertical resistance is generally a gene-for-gene relationship in the sense that a certain avirulence gene of the pathogen is opposed to a certain resistance gene of the plant. This means that vertical resistance is usually monogenic and therefore the easiest to break through.
  • the horizontal resistance is not inherited monogenously, but is usually determined by a series of loci. The horizontal resistance does not lead to complete resistance, as vertical resistance can, but is generally more permanent since many loci are involved.
  • HR hypersensitive reaction
  • the SAR represents an interesting special case of plant resistance to pathogens. It is characteristic here that a plant which has a SAR due to an infection by a specific pathogen does not only acquire the acquired resistance to the pathogen producing the SAR owns, but towards a much broader spectrum of pathogens.
  • the SAR is a very desirable reaction of the plant, since in many cases it results in a broad resistance that comes close to horizontal resistance (see, for example, Ryals et al. (1992) SEB Symposium 49, 205-229.
  • the mechanisms that lead to the formation of the SAR are partially understood.
  • SAR correlates with an increased level of salicylic acid (cf.
  • WO 95/31564 describes in a general way that the nucleotide sequence or sequences which are described in connection with localized cell death and the generation of SAR can comprise one or more genes, the specific exemplary embodiment being the resistance gene Cf-9 and the Avirulenzgen Ayr9 describes.
  • WO 95/31564 mentions the following possible approaches: an enzyme-conjugating enzyme, the gene VI protein from Cauliflower Mosaic Virus, a viral coat protein in simultaneous presence of a corresponding plant resistance gene, a bacterial hairpin protein, the N 'gene from tobacco, the potato virus coat protein and the avirulent dominant, as well as various resistance and avirulence gene combinations (e.g. Cf-2 from tomato and Ayr2 from C. fulvum, Cf-4 from tomato and Ayr4 from C. fulvum). Furthermore, an RNAse, the diphtheria toxin and proton pumps such as bacterial proton pumps are mentioned.
  • SAR is a very facultye resistance phenomenon.
  • the problem is that the SAR has not yet been able to be treated in breeding because presumably too many loci are involved and / or the gene products are unknown. It is therefore one of the tasks of bio-technological research to show alternative ways for both localized cell death and the SAR that is often associated with it.
  • the present invention is therefore based on the object of providing nucleic acid molecules with the aid of which localized cell death and optionally additionally systemically acquired resistance (SAR) can be triggered in plants or plant cells.
  • Another object of the invention is to provide nucleic acid molecules which can serve to produce male sterility in plants. Further objects of the invention will become apparent from the following description.
  • nucleic acid sequences can be used specifically to trigger localized cell death by triggering the generation of a protein or protein fragment, the enzymatic activity of which causes cell death.
  • a nucleic acid sequence from Erwinia amylovora which is a secreted form a Levansucrase coded, leads to the formation of HR in plants, which can also be coupled with the occurrence of SAR.
  • nucleic acid molecules which encode proteins or fragments thereof which, when expressed, lead to the death of the cell.
  • nucleic acid molecules according to the invention are nucleic acid molecules which encode proteins with the biological activity of a fructosyl transferase or a biologically active fragment thereof.
  • nucleic acid sequence is a nucleic acid sequence which encodes proteins with the biological activity of a levan sucrase or a biologically active fragment thereof, in particular a secreted levan sucrase.
  • biologically active fragment means that the mediated biological activity is sufficient to produce cell death.
  • Nucleic acid sequences which encode proteins with the enzymatic activity of a levan sucrase have been described from various organisms, e.g. from, Bacillus amyloliquefaciens (Tang et al. (1990) Gene 96, 89-93), Bacillus subtilis (Fönet et al. (1984) Biochem. Biophys. Res. Commun. 119, 795-800), Erwinia amylovora ( Geier and Geider (1993) Physiol. Mol. Plant Pathol. 42, 387-404; DE-Al 42 27 061).
  • a nucleic acid molecule according to the invention comprises the coding region from Erwinia amylovora mentioned in Example 1.
  • the present invention relates to nucleic acid molecules whose coding regions differ from sequences of the above-mentioned nucleic acid molecules due to the degeneration of the genetic code and which are a protein or encode a fragment thereof that has the biological activity of a levan sucrase, in particular a secreted levan sucrase.
  • nucleic acid sequence which encodes a protein with the biological activity of a levan sucrase or a biologically active fragment thereof can also be sequences which hybridize with one of the nucleic acid molecules described above.
  • biologically active fragments refers to fragments that can cause the plant cell to die.
  • hybridization means hybridization under conventional hybridization conditions, preferably under stringent conditions, as described, for example, in Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. Nucleic acid sequences that hybridize with the above-mentioned molecules can e.g. can be isolated from genomic or from cDNA libraries.
  • nucleic acid sequences can be identified and isolated using the known nucleic acid molecules described above or parts of these molecules or the reverse complements of these molecules, e.g. by means of hybridization according to standard methods (see e.g. Sambrook et al., op. cit.).
  • nucleic acid molecules can be used as the hybridization probe that have exactly or essentially the nucleotide sequences listed above or parts of these sequences.
  • the used as a hybridization probe fragments may also be synthetic fragments spindles han ⁇ , HERGÉ by means of the conventional synthesizing methods and the sequence of which were ⁇ represents coincides with that of a known levansucrase-encoding Nucleinklaremole- CRWT substantially.
  • the molecules hybridizing with the known nucleic acid molecules also include fragments, derivatives and allelic variants of the DNA molecules described above, which encode a levan sucrase or a biological, i.e. enzymatically active fragment thereof. Fragments are understood to mean parts of the nucleic acid molecules that are long enough to encode a polypeptide with the enzymatic activity of a Levan sucrase or a comparable enzymatic activity that causes localized cell death.
  • the term derivative in this context means that the sequences of these molecules differ from the sequences of the above-described nucleic acid molecules at one or more positions and have a high degree of homology to these sequences.
  • Homology means a sequence identity of at least 40%, in particular an identity of at least 60%, preferably over 80% and particularly preferably over 90%.
  • the deviations from the nucleic acid molecules described above may have arisen through deletion, addition, substitution, insertion or recombination.
  • nucleic acid molecules which are homologous to the molecules described above and represent derivatives of these molecules are generally variations of these molecules which represent modifications which have the same biological function. This can involve both naturally occurring variations, for example sequences from other organisms, or mutations, it being possible for these modifications to have occurred naturally or to have been introduced by targeted mutagenesis. Furthermore, the variations can be synthetic. act sequences.
  • allelic variants can be both naturally occurring and synthetically produced variants or those produced by recombinant DNA techniques.
  • the proteins encoded by the different variants of the nucleic acid molecules have certain common characteristics. For this, e.g. Enzyme activity, molecular weight, immunological reactivity, conformation etc. belong. Other common characteristics can include physical properties such as e.g. represent the running behavior in gel electrophoresis, chromatographic behavior, sedimentation coefficients, solubility, spectroscopic properties, stability, optimum pH, optimum temperature, etc. Furthermore, the products of the reactions catalyzed by the proteins can of course have common or similar features.
  • the proteins encoded by the nucleic acid sequences have levan sucrase activity. The detection of the enzymatic activity of levan sucrase can be carried out, for example, by the detection of the formation of levan (cf.
  • the nucleic acid molecules according to the invention can be any nucleic acid molecules, in particular DNA or RNA molecules, for example cDNA, genomic DNA, mRNA etc. They can be naturally occurring molecules or those produced by genetic engineering or chemical synthesis methods.
  • nucleic acid molecules are present ⁇ the invention to regulatory elements linked to the ensure transcription and translation in the plant cell.
  • a particular advantage of the invention is that local cell death in plants can optionally be triggered in a targeted manner using the nucleic acid molecules according to the invention.
  • any promoter which is functional in the plants selected for the transformation and which fulfills the condition that the expression regulated by it leads to localized necrosis and that the plant does not become too large is suitable for the promoter mentioned Dying brings. Promoters which are specifically induced locally when infected by pathogens appear to be particularly useful for this purpose.
  • pathogen in the context of the present invention includes fungi, bacteria, viruses, insects and nematodes. Such promoters are known and described in the literature, cf. eg Martini et al.
  • RNA + RNA is isolated from a tissue infected with a specific pathogen and a cDNA library is created.
  • cDNA clones based on poly (A) + RNA molecules from a non-infected tissue are used to identify those clones from the first bank whose hybrid poly (A) + RNA is used -Molecules are only induced when the pathogen is infected.
  • Promoters are then isolated with the help of these cDNAs identified in this way, which can then be used for the expression of the coding nucleic acid sequences described here.
  • the nucleic acid sequence is in combination with the potato prpl-1 promoter.
  • nucleic acid sequence responsible for cell death with tissue-specific or development-specific promoters active in plants.
  • a nucleic acid molecule in which the coding nucleic acid sequence is under the control of an anther- or tapetum-specific promoter is particularly preferred.
  • Transposons are known to excite in somatic tissues. Such excisions result in the promoter and coding sequence being brought into direct contact and thus lead to the formation of the enzymatic activity responsible for the localized cell death. Transposons are described and cloned in the literature and are available in a wide range, e.g.
  • nucleic acid molecules according to the invention for generating a local cell death can in addition to the be ⁇ signed application to generate a systemic erwor ⁇ surrounded resistance (SAR) to pathogens and thus to He ⁇ generation of plants, the integrated resistance by an increased Krank ⁇ distinguished, even for the production of male sterile plants can be used.
  • Male sterile plants play an important role in plant breeding, especially in hybrid breeding.
  • the nucleic acid sequence coding for the enzymatic activity causing the cell death is coupled with an anther- or tape-specific promoter. Examples of such motors are mentioned, for example, in W092 / 13956 and W092 / 13957.
  • a restorer gene which can be used together with the nucleic acid sequence according to the invention, would suppress the enzymatic activity causing the cell death.
  • the region encoding a levan sucrase were used, the formation of the product, ie the levan, would be influenced by a simultaneous expression of a levanase in the cell space.
  • the expression of a corresponding antisense construct would influence the enzymatic activity causing the localized cell death due to antisense suppression.
  • the expression of the nucleic acid molecules according to the invention and thus the resulting cell-killing activity could be influenced by the phenomenon of cosuppression by the additional introduction of sense constructs into the plant cell.
  • nucleic acid sequences according to the invention can be used together with promoters which are induced in plants by abiotic stimuli, e.g. Chemicals, ozone, UV radiation, extreme temperatures, drought, salt can be induced.
  • promoters can be found in the literature, e.g. in Williams et al. (1992) Biotechnology 10, 540.
  • the enzymatic activity responsible for local cell death can be localized in any compartment of the plant cell.
  • the shape of the protein or a fragment thereof is selected which is localized in the extracellular space, ie in the apoplast.
  • the coding sequence of levansucrase is used, as has been isolated from Erwinia amylovora.
  • the nucleic acid molecule according to the invention contains a termination signal for the termination of the transcription and the addition of a poly-A tail to the corresponding transcript.
  • termination signals are known and can be interchanged with one another as desired.
  • An example of such a sequence is the termination signal of the octopine synthase gene from Agrobacterium tumefaciens.
  • nucleic acid sequences of the invention can be supplemented by enhancer sequences or other regulatory sequences.
  • regulatory sequences include e.g. also signal sequences that ensure that the gene product is transported to a specific compartment.
  • a nucleic acid molecule according to the invention preferably comprises a nucleotide sequence which codes an amino acid sequence which ensures the secretion of the protein.
  • the present invention further relates to vectors, in particular plasmids, cosmids, viruses, bacteriophages and other vectors common in genetic engineering, which contain the above-described nucleic acid molecules according to the invention and, if appropriate, for the transfer of the nucleic acid molecules according to the invention into plants or plant cells can be used.
  • vectors in particular plasmids, cosmids, viruses, bacteriophages and other vectors common in genetic engineering, which contain the above-described nucleic acid molecules according to the invention and, if appropriate, for the transfer of the nucleic acid molecules according to the invention into plants or plant cells can be used.
  • the invention also relates to host cells which are genetically modified with a nucleic acid molecule or vector according to the invention.
  • host cells which are genetically modified with a nucleic acid molecule or vector according to the invention.
  • These can be prokaryotic as well as eukaryotic cells.
  • it may be Mikroor ⁇ organisms, such as bacteria, viruses, fungi containing the OF INVENTION ⁇ to the invention nucleic acid sequences, that Mikroor- ganisms that are genetically modified with a nucleic acid molecule according to the invention.
  • it can also tie ⁇ generic cells.
  • nucleic acid molecules according to the invention there is now the possibility, using genetic engineering methods, to modify plant cells to the extent that they have a new enzymatic activity compared to wild-type cells and, as a result, to localize in plants which contain such cells Cell death can come.
  • the host cells according to the invention are plant cells which, owing to the presence and expression of an additionally introduced nucleic acid molecule according to the invention, have an enzymatic activity in comparison to non-transformed cells which is responsible for local cell death is.
  • these are transgenic plant cells which express a levan sucrase under the control of a pathogen-specific promoter.
  • the nucleic acid molecule according to the invention can be stably integrated into the genome of the plant cell.
  • the nucleic acid molecule encoding the enzymatic activity that causes cell death can be introduced into the cell as a self-replicating system.
  • the invention also relates to transgenic plants which contain the transgenic plant cells according to the invention described above, in which the nucleic acid molecules are integrated into the plant genome.
  • Plants are also the subject of the invention, in the cells of which a nucleic acid molecule according to the invention is present in self-replicating form, ie the plant cell contains the foreign DNA on an independent nucleic acid molecule.
  • the plants which are transformed with the nucleic acid molecules according to the invention and in which a protein responsible for localized cell death is synthesized due to the introduction of such a molecule can in principle be any plant. It is preferably a monocotyledon or dicotyledon crop.
  • Examples of monocot plants are the plants belonging to the genera Avena (oats), Triticum (wheat), Seeale (rye), Hordeum (barley), Oryza (rice), Panicum, Pennisetum, Setaria, Sorghum (millet), Zea (corn) belong.
  • Avena oats
  • Triticum wheat
  • Seeale rye
  • Hordeum barley
  • Oryza rice
  • Panicum Pennisetum
  • Setaria Sorghum
  • Sorghum mofetil
  • Zea corn
  • dicotyledonous crops cotton, legumes, such as legumes and in particular alfalfa, soybean, rapeseed, tomato, sugar beet, potato, ornamental plants, trees are to be mentioned among others.
  • Other useful plants can be fruit (in particular apples, pears, cherries, grapes, citrus, ananas and bananas), oil palms, tea, cocoa and coffee bushes, tobacco, sisal and, in the case of medicinal plants, rauwolfia and digitalis. Cereals, wheat, rye, oats, barley, rice, corn and millet, sugar beet, rapeseed, soy, tomato and potato are particularly preferred.
  • the invention furthermore relates to propagation material from plants according to the invention, for example seeds, fruits, cuttings, tubers, rhizomes etc., this propagation material containing transgenic plant cells described above.
  • the present invention also relates to parts of the plants according to the invention, such as e.g. Protoplasts, plant cells and calli that contain nucleic acid molecules according to the invention.
  • the invention also relates to plants which, owing to the expression of the nucleic acid molecules according to the invention, have an increased salicylic acid concentration in comparison to plants which do not contain the nucleic acid molecules.
  • the invention further relates to plants which, in comparison to plants, contain the nucleic acid molecules according to the invention not included, characterized by increased disease resistance.
  • these are plants which, owing to the expression of a levan sucrase gene from E. amylovora, show local cell death which may be associated with the expression of a SAR.
  • the present invention also relates to plants which are male-sterile due to the expression of a nucleic acid molecule according to the invention.
  • the present invention relates to a method by means of which it is possible to produce plants which show a localized cell death and which may additionally be characterized by the acquisition of an SAR, and plants which are male-sterile due to the localized cell death .
  • plants or plant cells can be modified with the aid of conventional genetic engineering transformation methods such that a nucleic acid molecule according to the invention is integrated into the plant genome, i.e. that stable transformants are generated.
  • a nucleic acid molecule according to the invention the expression of which in the plant cell causes the cell to die, can be contained in the plant cell or the plant as a self-replicating system.
  • the nucleic acid molecules according to the invention can e.g. be contained in a virus with which the plant or plant cell comes into contact.
  • plant cells which have an activity causing cell death due to the expression of a nucleic acid molecule according to the invention are produced by a process which comprises the following steps: (a) Production of an expression cassette which comprises the following sequences:
  • nucleic acid sequence which encodes a protein or a fragment thereof, the enzymatic activity of which causes localized cell death in plants, the nucleic acid sequence being coupled in sense orientation to the 3 'end of the promoter;
  • nucleic acid molecules according to the invention can as a self-replicating system in ⁇ These crops zenzelle or plant are introduced.
  • the invention is also the use of a pathogen-specific promoter, in particular the prpl-1 promoter for the production of plants in which a cell death occurs thanksi ⁇ lized and / or the at least one typical for a systemic acquired resistance trait and / or increased Have disease resistance compared to wild ⁇ type plants.
  • a pathogen-specific promoter in particular the prpl-1 promoter for the production of plants in which a cell death occurs thanksi ⁇ lized and / or the at least one typical for a systemic acquired resistance trait and / or increased Have disease resistance compared to wild ⁇ type plants.
  • the invention also relates to the use of nucleic acid sequences ⁇ that tivity a protein having the enzymatic Akti ⁇ a levansucrase encode for generating of plant zen, which are characterized by a localized cell death, as well as for the production of a localized cell death in plants. Also, the present invention relates to the Verwen ⁇ dung such nucleic acid to produce a systemic acquired resistance in plants, to increase the salicylic acid concentration in plants and / or He ⁇ disease resistance heightening in plants.
  • the invention further relates to the use of a protein with the enzymatic activity of a levan sucrase in order to cause localized cell death in plants.
  • the present invention also relates to the use of nucleic acid sequences which encode proteins with the biological activity of a levan sucrase, or such proteins, for producing male sterility in plants.
  • the present invention thus encompasses every possible form of use of the nucleic acid molecules according to the invention, the expression of which in plants causes the death of cells, and of the proteins or fragments thereof according to the invention, the enzymatic activity of which causes cell death.
  • cloning vectors which contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells.
  • examples of such vectors are pBR322, pUC series, M13mp series, paCYC184 etc.
  • the desired sequence can be introduced into the vector at a suitable restriction interface.
  • the plasmid obtained is used for the transformation of E. coli cells.
  • Transformed E. coli cells are grown in a suitable medium and then harvested and lysed.
  • the plasmid is recovered.
  • analysis method for characterizing the plasmid DNA obtained generally restriction analyzes, gel electrophoresis and other biochemical-molecular biological methods are used. After each manipulation, the plasmid DNA can be cleaved and the DNA fragments obtained can be linked to other DNA sequences.
  • Each plasmid DNA sequence can be cloned into the same or other plasmids.
  • a large number of known techniques are available for introducing DNA into a plant host cell, and the person skilled in the art can determine the appropriate method in each case without difficulty. These techniques include the transformation of plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agents, the fusion of protoplasts, the direct gene transfer of isolated DNA into protoplasts, the electroporation of DNA, the introduction of DNA by means of the biolistic method and other possibilities.
  • the nucleic acid molecules according to the invention for example can be introduced into the cells via a viral infection as a self-replicating system without subsequent integration into the plant genome.
  • the Ti or Ri plasmid is used for transformation of the plant cell, it should be at least the right border, but often the right and left Be ⁇ limitation of the T-DNA contained in the Ti- and Ri-plasmid as Flanking region to the genes to be introduced linked to ⁇ .
  • the DNA to be introduced should be cloned into special plasmids, either in an intermediate or in a binary vector.
  • the intermediate vectors can on ⁇ Due to sequences that are homologous to sequences in the T-DNA by homologous recombination into the Ti or Ri-Plas ⁇ the Agrobacteria mid be integrated. This also contains the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate in agrobacteria.
  • the intermediate vector can be transferred to Agrobacterium tumefaciens by means of a helper plasmid
  • Binary vectors can replicate in E. coli as well as in Agrobacteria. They contain a selection marker gene and a linker or polylinker, which are framed by the right and left T-DNA border region. They can be transformed directly into the agrobacteria
  • the Agrobacterium serving as the host cell should contain a plasmid which carries a vir region.
  • the vir region is usually necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be present.
  • the agrobacterium transformed in this way is used for the transformation of plant cells.
  • T-DNA for the transformation of plant cells has been intensively investigated and is sufficient in EP 120 515; Hoekema in: The Binary Plant Vector System, Offsetdrokkerij Kanters BV, Alblasserdam (1985) Chapter V; Fraley et al. (1993) Crit. Rev. Plant. Be. 4, 1-46 and An et al. (1985) EMBO J. 4, 277-287.
  • plant explants can expediently be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes. From the infected plant material (e.g.
  • leaf pieces, stem Segments, roots, but also protoplasts or suspension-cultivated plant cells can then regenerate whole plants again in a suitable medium, which can contain antibiotics or biocides for the selection of transformed cells.
  • the plants are regenerated by customary regeneration methods using known nutrient media.
  • the plants thus obtained can then be examined for the presence of the introduced DNA.
  • Other possibilities of introducing foreign DNA using the biolostic method or by means of protoplast transformation are known (cf., for example, Willmitzer L. (1993) Transgenic Plants, in: Biotechnology, A Multi-Volume Comprehensive Treatise (HJ Rehm, G. Reed , A. Pühler, P. Stadler, eds., Vol. 2, 627-659, VCH Weinheim - New York - Basel - Cambridge).
  • Zen Alternative systems for Tansformation of monocotyledonous Pflan ⁇ are the transformation by means of the biolistic An ⁇ set (Wan and Lemaux (1994) Plant Physiol 104, 37-48;. Vasil et al (1993) Bio / Technology 11, 1553-1558.; Ritala et al. (1994) Plant Mol. Biol. 24, 317-325; Spencer et al. (1990) Theor. Appl. Genet. 79, 625-631), the protoplast transformation, the electroporation of partially permeabilized Cells, the introduction of DNA using glass fibers.
  • EP 292 435 describes a process by means of which fertile plants can be obtained starting from a slimy, soft (friable) granular corn callus. Shillito et al.
  • the introduced DNA is integrated in the genome of the plant cell, it is generally stable there and is also retained in the progeny of the originally transformed cell. It normally contains a selection marker which imparts resistance to the transformed plant cells to a biocide or an antibiotic such as kanamycin, G418, bleomycin, hygromycin, methotrexate, glyphosate, streptomycin, sulfonylurea, gentamycin or phosphinotricin and others.
  • the individually selected marker should therefore allow the selection of transformed cells over cells that lack the inserted DNA.
  • the transformed cells grow within the plant in the usual way (see also McCormick et al. (1986) Plant Cell Reports 5, 81-84).
  • the resulting plants can be grown normally and crossed with plants that have the same transformed genetic makeup or other genetic makeup.
  • the resulting hybrid individuals have the corresponding phenotypic properties. Seeds can be obtained from the plants.
  • transgenic lines can be determined by conventional methods, which are homozygous for the new nucleic acid molecules and which investigate and investigate their phenotypic behavior with regard to localized cell death and / or SAR and / or increased disease resistance and / or male sterility with that of hemizygote lines.
  • Figure 1 shows the appearance of necrotic areas in transgenic tobacco plants with the construct
  • Figure 2 shows the amount of salicylic acid in transgenic tobacco plants (1-5) compared to wild-type plants (6-7).
  • Figure 3 shows the result of a Northern blot experiment. 30 ⁇ g poly (A) + mRNA from different transgenic tobacco plants (lane 1-5) and two non-transformed tobacco plants (lane 6-7) were used for the analysis. A cDNA of the PR-1 l gene was used as a probe. 23
  • the vector pBluescript II SK (Stratagene) was used for cloning in E. coli.
  • E. coli strain DH5alpha (Bethesda Research Laboratories, Gaithersburgh, USA) was used for the Bluescript vector and the Lss8 constructs.
  • the leaves were then used for callus induction on MS medium with 1.6% glucose, 5 mg / 1 naphthylacetic acid, 0.2 mg / 1 benzylaminopurine, 250 mg / 1 claforan, 50 mg / 1 kanamycin and 0.8 % Bacto agar placed. After incubation for one week at 25 ° C. and 3000 lux, the leaves were induction on MS medium with 1.6% glucose, 1.4 mg / 1 zeatin ribose, 20 ⁇ g / 1 naphthylacetic acid, 20 ⁇ g / 1 giberellic acid, 250 mg / 1 Claforan, 50 mg / 1 kanamycin and 0.8% Bacto agar.
  • RNA extraction and Northern blot experiments RNA was isolated from frozen plant material, as described in Logemann et al. (1987) Anal. Biochem. 163, 21-26. The RNA was denatured in 40% formamide. The .RNA was then separated by gel electrophoresis on formaldehyde / agarose gels and blotted on nylon membranes (Hybond N; Amersham, UK) after the gel run. Hybridization against a radioactively labeled DNA probe was carried out according to standard methods (e.g. Sambrook et al, op. Cit.).
  • Potato plants (Solanum tuberosum) were kept in the greenhouse ⁇ house at 60% humidity and 22 ° C for 16 hours in the light and 15 ° C for 8 hours in darkness.
  • Tobacco plants (Nicotiana tabacum) were kept in the greenhouse at 60% humidity and 25 ° C for 14 hours in the light and 20 ° C for 10 hours in the dark. 7. Determination of salicylic acid contents:
  • the resulting binary vector thus contains the prpl-1 promoter region and the termination signal of the octopine synthase gene (OCS) separated by restriction sites of the pUC18 polylinker, which allows the insertion of coding regions and thus the construction of appropriate expression cassettes.
  • OCS octopine synthase gene
  • Transgenic tobacco and potato plants were transformed, selected and regenerated as described above. After rooting in stone culture, approx. 50 independent transformants were transferred to soil in the greenhouse. 6 to 8 lines which had a phenotype clearly identified by the appearance of necrotic spots could be identified (see FIG. 1). The analysis of these necrotic areas for the presence of Levan by the method described above clearly provided evidence of Levan. These plants, which had localized cell death due to the expression of the chimeric gene construct pLSS8, were then subjected to further analyzes in the greenhouse.
  • the salicylic acid content of various transformants was determined using the methods given above. As can be seen from Figure 2, the transgenic tobacco plants, which are characterized by localized cell death, have a 2-8 times higher amount of salicylic acid compared to wild-type plants.
  • SAR Systemic acquired resistance
  • PR proteins pathogenesis-related proteins
  • PR proteins pathogenesis-related proteins
  • FIG. 3 The expression of PR proteins in plants which express the chimeric Lss8 gene was examined by means of Northern blot analysis. As can be seen in FIG. 3, the expression of the homologous PRI-1 gene can be detected both in green and in areas of the tobacco plants which already have necrotic spots, while in non-transformed areas Control plants are not.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

The invention relates to nucleic acid molecules for production of localised cell death in plants, and vectors containing said nucleic acid molecules. It also relates to plant cells and plants which are genetically modified by said nucleic acid molecules.

Description

Lokalisierter Zelltod in Pflanzen Localized cell death in plants
Die vorliegende Erfindung betrifft Nucleinsäuremoleküle, die bei Expression in Pflanzen zur Erzeugung eines lokalisierten Zelltods führen, sowie Pflanzenzellen und Pflanzen, die sol¬ che Nucleinsäuremoleküle enthalten.The present invention relates to nucleic acid molecules which, when expressed in plants, lead to the production of localized cell death, and to plant cells and plants which contain such nucleic acid molecules.
Pflanzen werden durchweg von verschiedensten Pathogenen at¬ tackiert. Ein besonderes Problem in bezug auf den Angriff von Pflanzen durch Pathogene entsteht bei der heutigen Form der Landwirtschaft, die dadurch charakterisiert ist, daß aufgrund des großflächigen Anbaus von Monokulturen mittels züchterischer Methoden eingebrachte Resistenzen relativ rasch durch Mutationen auf Seiten der Schädlinge überkommen werden.Plants are attacked by various pathogens throughout. A particular problem with regard to the attack of plants by pathogens arises in the current form of agriculture, which is characterized in that, due to the large-scale cultivation of monocultures, resistance introduced by means of breeding methods is overcome relatively quickly by mutations on the part of the pests.
Prinzipiell werden zwei Arten der Resistenz bei Pflanzen un¬ terschieden, die .vertikale und die horizontale Resistenz. Bei der vertikalen Resistenz handelt es sich in der Regel um eine Gen-für-Gen-Beziehung in dem Sinne, daß einem bestimm¬ ten Avirulenzgen des Pathogens ein bestimmtes Resistenzgen der Pflanze gegenübersteht. Dies bedeutet, daß die vertikale Resistenz in der Regel monogen ist und daher auch am leichtesten durchbrochen wird. Die horizontale Resistenz wird nicht monogen vererbt, sondern in der Regel durch eine Reihe von Loci bestimmt. Die horizontale Resistenz führt zu keiner vollständigen Resistenz, wie dies die vertikale Resi¬ stenz vermag, ist jedoch in der Regel, da viele Loci invol- viert sind, dauerhafter.In principle, two types of resistance are distinguished in plants, vertical and horizontal resistance. The vertical resistance is generally a gene-for-gene relationship in the sense that a certain avirulence gene of the pathogen is opposed to a certain resistance gene of the plant. This means that vertical resistance is usually monogenic and therefore the easiest to break through. The horizontal resistance is not inherited monogenously, but is usually determined by a series of loci. The horizontal resistance does not lead to complete resistance, as vertical resistance can, but is generally more permanent since many loci are involved.
Im Falle der vertikalen Resistenz, d.h. im Falle des Vorlie- gens eines Resistenzgens auf der Seite der Pflanze und eines Avirulenzgens auf der Seite des Pathogens, äußert sich die Resistenz in dem Auftreten von lokalen Nekrosen, die mit einer hypersensitiven Reaktion seitens der Pflanze einherge¬ hen.In the case of vertical resistance, ie in the presence of a resistance gene on the plant side and an avirulence gene on the pathogen side, the resistance manifests itself in the occurrence of local necrosis, which is associated with a hypersensitive reaction on the part of the plant goes hand in hand.
Obwohl die hypersensitive Reaktion, die im folgender, als "HR" bezeichnet wird, in ihren Einzelheiten nicht vollstän¬ dig verstanden ist, ist es deutlich, daß die pflanzlichen Wirtszellen im Bereich der HR einen raschen Zelltod erlei¬ den. Zum einen führt dieser rasche Zelltod zum Einschluß und damit zur Lokalisierung des Pathogens, zum anderen ist davon auszugehen, daß das Pathogen durch Radikale, die während der HR entstehen, geschädigt wird. Darüber hinaus führt eine HR in vielen Fällen zum Phänomen der sogenannten systemisch er¬ worbenen Resistenz. Diese systemisch erworbene Resistenz wird allgemein nach der englischen Bezeichnung "systemic acquired resistance" als SAR bezeichnet.Although the details of the hypersensitive reaction, which is referred to below as "HR", are not completely understood, it is clear that the plant host cells suffer rapid cell death in the area of HR. On the one hand, this rapid cell death leads to the inclusion and localization of the pathogen, on the other hand, it can be assumed that the pathogen is damaged by radicals that arise during HR. In addition, HR leads in many cases to the phenomenon of so-called systemically acquired resistance. This systemically acquired resistance is generally referred to as SAR after the English term "systemic acquired resistance".
Die SAR stellt einen interessanten Spezialfall der pflanzli¬ chen Resistenz gegenüber Pathogenen dar. Kennzeichnend ist dabei, daß eine Pflanze, die eine SAR aufgrund einer Infek¬ tion durch ein bestimmtes Pathogen aufweist, die erworbene Resistenz nicht nur gegenüber dem die SAR erzeugenden Patho¬ gen besitzt, sondern gegenüber einem sehr viel breiteren Spektrum von Pathogenen.The SAR represents an interesting special case of plant resistance to pathogens. It is characteristic here that a plant which has a SAR due to an infection by a specific pathogen does not only acquire the acquired resistance to the pathogen producing the SAR owns, but towards a much broader spectrum of pathogens.
Insofern ist die SAR eine sehr erstrebenswerte Reaktion der Pflanze, da sie in vielen Fällen in einer breiten Resistenz mündet, welche einer horizontalen Resistenz nahekommt (vgl. z.B. Ryals et al. (1992) SEB Symposium 49, 205-229. Die Mechanismen, die zur Bildung der SAR führen, sind parti¬ ell verstanden. In vielen Fällen ist gezeigt worden, daß zur Ausbildung einer SAR eine lokale Nekrose von Zellen, verbun¬ den mit einer HR notwendig ist. Eine Nekrose, die allein das Ergebnis einer Verwundung darstellt, oder aufgrund von ande¬ ren abiotischen Stressoren induziert wird, ist in der Regel nicht ausreichend zur Erzeugung einer SAR. Des weiteren ist gezeigt worden, daß in vielen Fällen die SAR mit einem er¬ höhten Niveau an Salicylsäure korreliert (vgl. z.B. Metraux et al. (1990) Science 250, 1004-1006; Malamy et al. (1990) Science 250, 1002-1004) . Dies ist auch dadurch gezeigt wor- den, daß exogene Salicylsäure, wenn sie zu nicht infizier¬ ten Pflanzen gegeben wird, eine SAR induzieren kann (vgl z.B. White (1979) Virology 99, 410-412; Palva et al (1994) Molecular Plant-Microb. Interactions 7, 356-363) . Des weite¬ ren ist beobachtet worden, daß m transgenen Pflanzen, in denen über die Expression einer bakteriellen Saiicylat- Hydroxylase die Salicylsäuremenge verringert wurde, keine SAR ausgebildet werden kann (Gaffney et al . (1993) Science 261, 754-756) . Die SAR kann auch durch eine Reihe von ande¬ ren Chemikalien, wie z.B. 2, 6-Dichlor-Isonicotmsäure indu¬ ziert werden (Uknes et al . (1992) , The Plant Cell 4, 645- 656) .In this respect, the SAR is a very desirable reaction of the plant, since in many cases it results in a broad resistance that comes close to horizontal resistance (see, for example, Ryals et al. (1992) SEB Symposium 49, 205-229. The mechanisms that lead to the formation of the SAR are partially understood. In many cases it has been shown that local necrosis of cells associated with HR is necessary for the formation of an SAR. A necrosis which is solely the result of a wound, or induced due to other abiotic stressors is generally not sufficient to produce an SAR. Furthermore, it has been shown that in many cases SAR correlates with an increased level of salicylic acid (cf. eg Metraux et al (1990) Science 250, 1004-1006; Malamy et al. (1990 ) Science 250, 1002-1004. This is also shown by what that exogenous salicylic acid, when it is not added to infizier ¬ ten plants, can induce the SAR (see, for example, White (1979) Virology 99, 410-412; Palva et al (1994) Molecular Plant-Microb Interactions 7, 356th -363). Ren the wide ¬ has been observed that m transgenic plants in which the salicylic acid was decreased by the expression of a bacterial Saiicylat- hydroxylase, no SAR can be formed (Gaffney et al. (1993) Science 261, 754-756). The SAR can also be induced by a number of other chemicals, such as, for example, 2,6-dichloroisonicotmic acid (Uknes et al. (1992), The Plant Cell 4, 645-656).
In der Literatur sind bisher verschiedene Systeme beschrie¬ ben worder., die zu einem lokalisierten Zelltod führen Bei¬ spiele dafür sind die Expression einer bakteriellen Ribo- nuclease m transgenen Pflanzen (Strittmatter et al . (1995) Biotechnology 13, 1085-1089) . Ein weiteres System ist die gleichzeitige Expression von Resistenzgenen aus einer Wirts¬ pflanze und korrespondierenden Avirulenzgenen aus Pathogenen (WO 91/15585) . Ein spezifisches Beispiel ist die Expression des Ayr9-Gens aus dem Pilz Cladosporium fulvum und des Cf-9- Gens aus Tomate (WO 95/31564; für eine Übersicht vgl. auch de Witt (1992) Annual Review in Plant Pathology 30, 301-418, zur Benennung weiterer für eine solche Problemlösung m Frage kommender Avirulenz- und Resistenzgene) . In WO 95/31564 wird in allgemeiner Art beschrieben, daß die Nucleotidsequenz oder -Sequenzen, welche im Zusammenhang mit lokalisiertem Zelltod und der Erzeugung von SAR beschrieben werden, ein oder mehrere Gene umfassen können, wobei das spezifische Ausführungsbeispiel das Resistenzgen Cf-9 und das Avirulenzgen Ayr9 beschreibt .Various systems have so far been described in the literature which lead to localized cell death. Examples include the expression of a bacterial ribonuclease in transgenic plants (Strittmatter et al. (1995) Biotechnology 13, 1085-1089). Another system is the simultaneous expression of resistance genes from a host plant and corresponding avirulence genes from pathogens (WO 91/15585). A specific example is the expression of the Ayr9 gene from the fungus Cladosporium fulvum and the Cf-9 gene from tomato (WO 95/31564; for an overview see also de Witt (1992) Annual Review in Plant Pathology 30, 301- 418, to name other avirulence and resistance genes that come into question for such a solution to the problem). WO 95/31564 describes in a general way that the nucleotide sequence or sequences which are described in connection with localized cell death and the generation of SAR can comprise one or more genes, the specific exemplary embodiment being the resistance gene Cf-9 and the Avirulenzgen Ayr9 describes.
Als weitere Beispiele für die Verwendung einer Nucleotidse¬ quenz oder die Kombination von Nucleotidsequenzen, die zu einer Pflanzenzellennekrosis und einer SAR führen, werden ιr. WO 95/31564 folgende mögliche Ansätze genannt: ein Ubιquιtιn-kon3ugιerendeε Enzym, das Gen-VI-Protein aus Cauliflower Mosaic Virus, ein virales Coat-Protein in gleichzeitiger Gegenwart eines entsprechenden pflanzlichen Resistenzgens, ein bakterielles Hairpin-Protein, das N'-Gen aus Tabak, das Kartoffelvirus-Hüllprotein und die avirulente Dominante, sowie verschiedene Resistenz- und Avirulenzgen- Kombinationen (z.B. Cf-2 aus Tomate und Ayr2 aus C. fulvum, Cf-4 aus Tomate und Ayr4 aus C. fulvum) . Des weiteren werden eine RNAse, das Diphtherietoxin sowie Protonenpumpen wie bakterielle Protonenpumpen genannt.As further examples for the use of a nucleotide sequence or the combination of nucleotide sequences which lead to plant cell necrosis and an SAR, ιr. WO 95/31564 mentions the following possible approaches: an enzyme-conjugating enzyme, the gene VI protein from Cauliflower Mosaic Virus, a viral coat protein in simultaneous presence of a corresponding plant resistance gene, a bacterial hairpin protein, the N 'gene from tobacco, the potato virus coat protein and the avirulent dominant, as well as various resistance and avirulence gene combinations (e.g. Cf-2 from tomato and Ayr2 from C. fulvum, Cf-4 from tomato and Ayr4 from C. fulvum). Furthermore, an RNAse, the diphtheria toxin and proton pumps such as bacterial proton pumps are mentioned.
Wie bereits oben beschrieben, ist die SAR ein sehr atrrakti- ves Resistenzphänomen. Das Problem besteht jedoch darin, daß die SAR züchterisch bisher nicht behandelt werden konnte, da vermutlich zu viele Loci involviert und/oder die Genprodukte nicht bekannt sind. Es ist somit eine der Aufgaben der bio¬ technologischen Forschung, alternative Wege sowohl für einen lokalisierten Zelltod als auch die damit häufig einherge¬ hende SAR aufzuzeigen.As already described above, SAR is a very atractive resistance phenomenon. The problem, however, is that the SAR has not yet been able to be treated in breeding because presumably too many loci are involved and / or the gene products are unknown. It is therefore one of the tasks of bio-technological research to show alternative ways for both localized cell death and the SAR that is often associated with it.
Der vorliegenden Erfindung liegt somit die Aufgabe zugrunde, Nucleinsäuremoleküle bereitzustellen, mit deren Hilfe in Pflanzen oder Pflanzenzellen ein lokalisierter Zelltod und gegebenenfalls zusätzlich eine systemisch erworbene Resi¬ stenz (SAR) ausgelöst werden können. Eine weitere Aufgabe der Erfindung besteht darin, Nucleinsäuremoleküle zu lie¬ fern, die dazu dienen können, in Pflanzen männliche Sterili¬ tät zu erzeugen. Weitere Aufgaben der Erfindung ergeben sich aus der folgenden Beschreibung.The present invention is therefore based on the object of providing nucleic acid molecules with the aid of which localized cell death and optionally additionally systemically acquired resistance (SAR) can be triggered in plants or plant cells. Another object of the invention is to provide nucleic acid molecules which can serve to produce male sterility in plants. Further objects of the invention will become apparent from the following description.
Diese Aufgaben werden durch Bereitstellung der in den Pa¬ tentansprüchen charakterisierten Ausführungsformen gelöst.These tasks are solved by providing the embodiments characterized in the claims.
Es wurde überraschend gefunden, daß bestimmte Nucleinsäure- sequenzen gezielt zur Auslösung des lokalisierten Zelltods eingesetzt werden können, indem sie die Erzeugung eines Pro¬ teins oder Proteinfragments auslösen, dessen enzymatische Aktivität den Zelltod bewirkt. Insbesondere konnte experi¬ mentell gezeigt werden, daß die Expression einer Nucleinsäu- resequenz aus Erwinia amylovora, die eine sekretierte Form einer Levansucrase codiert, in Pflanzen zur Ausbildung einer HR führt, die des weiteren mit dem Auftreten einer SAR ge¬ koppelt sein kann.It has surprisingly been found that certain nucleic acid sequences can be used specifically to trigger localized cell death by triggering the generation of a protein or protein fragment, the enzymatic activity of which causes cell death. In particular, it could be shown experimentally that the expression of a nucleic acid sequence from Erwinia amylovora, which is a secreted form a Levansucrase coded, leads to the formation of HR in plants, which can also be coupled with the occurrence of SAR.
Somit betrifft die vorliegende Erfindung Nucleinsäuremole¬ küle, die Proteine oder Fragmente davon codieren, die bei Expression zum Absterben der Zelle führen. In einer bevor¬ zugten Ausführungsform handelt es sich bei den erfindungsge¬ mäßen Nucleinsäuremolekülen um Nucleinsäuremoleküle, die Proteine mit der biologischen Aktivität einer Fructosyl- transferase oder eines biologisch aktiven Fragments davon codieren. In einer besonders bevorzugten Ausführungsform handelt es sich bei der Nucleinsäuresequenz um eine Nuclein- säuresequenz, die Proteine mit der biologischen Aktivität einer Levansucrase oder eines biologisch aktiven Fragments davon codiert, insbesondere einer sekretierten Levansucrase. Biologisch aktives Fragment bedeutet im Zusammenhang mit dieser Erfindung, daß die vermittelte biologische Aktivität zur Erzeugung eines Zelltods ausreicht .The present invention thus relates to nucleic acid molecules which encode proteins or fragments thereof which, when expressed, lead to the death of the cell. In a preferred embodiment, the nucleic acid molecules according to the invention are nucleic acid molecules which encode proteins with the biological activity of a fructosyl transferase or a biologically active fragment thereof. In a particularly preferred embodiment, the nucleic acid sequence is a nucleic acid sequence which encodes proteins with the biological activity of a levan sucrase or a biologically active fragment thereof, in particular a secreted levan sucrase. In the context of this invention, biologically active fragment means that the mediated biological activity is sufficient to produce cell death.
Nucleinsäuresequenzen, die Proteine mit der enzymaitschen Aktivität einer Levansucrase codieren, sind aus verschie¬ denen Organismen beschrieben worden, so z.B. aus, Bacillus amyloliquefaciens (Tang et al . (1990) Gene 96, 89-93) , Ba¬ cillus subtilis (Fönet et al . (1984) Biochem. Biophys . Res . Commun. 119, 795-800) , Erwinia amylovora (Geier und Geider (1993) Physiol. Mol. Plant Pathol . 42, 387-404; DE-Al 42 27 061) .Nucleic acid sequences which encode proteins with the enzymatic activity of a levan sucrase have been described from various organisms, e.g. from, Bacillus amyloliquefaciens (Tang et al. (1990) Gene 96, 89-93), Bacillus subtilis (Fönet et al. (1984) Biochem. Biophys. Res. Commun. 119, 795-800), Erwinia amylovora ( Geier and Geider (1993) Physiol. Mol. Plant Pathol. 42, 387-404; DE-Al 42 27 061).
In einer besonders bevorzugten Ausführungsform umfaßt ein erfindungsgemäßes Nucleinsäuremolekül die im Beispiel 1 be¬ nannte codierende Region aus Erwinia amylovora.In a particularly preferred embodiment, a nucleic acid molecule according to the invention comprises the coding region from Erwinia amylovora mentioned in Example 1.
Weiterhin betrifft die vorliegende Erfindung Nucleinsäuremo¬ leküle, deren codierende Regionen sich aufgrund der Degene¬ ration des genetischen Codes von Sequenzen der oben genann¬ ten Nucleinsäuremoleküle unterscheiden und die ein Protein oder ein Fragment davon codieren, daß die biologische Akti¬ vität einer Levansucrase aufweist, insbesonder einer sekre- tierten Levansucrase.Furthermore, the present invention relates to nucleic acid molecules whose coding regions differ from sequences of the above-mentioned nucleic acid molecules due to the degeneration of the genetic code and which are a protein or encode a fragment thereof that has the biological activity of a levan sucrase, in particular a secreted levan sucrase.
Bei der Nucleinsäuresequenz, die ein Protein mit der biolo¬ gischen Aktivität einer Levansucrase codiert oder ein biolo¬ gisch aktives Fragment davon, kann es sich auch um Sequenzen handeln, die mit einem der oben beschriebenen Nucleinsäure¬ moleküle hybridisieren. Der Begriff biologisch aktive Frag¬ mente bezieht sich auf Fragmente, die das Absterben der Pflanzenzelle bewirken können. Der Begriff "Hybridisierung" bedeutet im Rahmen dieser Erfindung eine Hybridisierung un¬ ter konventionellen Hybridisierungsbedingungen, vorzugsweise unter stringenten Bedingungen, wie sie beispielsweise in Sambrook et al . (1989) Molecular Cloning: A Laboratory Manual, 2. Auflage, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York, beschrieben sind. Nucleinsäuresequenzen, die mit den obengenannten Molekülen hybridisieren, können z.B. aus genomiεchen oder aus cDNA-Bi- bliotheken isoliert werden.The nucleic acid sequence which encodes a protein with the biological activity of a levan sucrase or a biologically active fragment thereof can also be sequences which hybridize with one of the nucleic acid molecules described above. The term biologically active fragments refers to fragments that can cause the plant cell to die. In the context of this invention, the term “hybridization” means hybridization under conventional hybridization conditions, preferably under stringent conditions, as described, for example, in Sambrook et al. (1989) Molecular Cloning: A Laboratory Manual, 2nd edition, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York. Nucleic acid sequences that hybridize with the above-mentioned molecules can e.g. can be isolated from genomic or from cDNA libraries.
Die Identifizierung und Isolierung derartiger Nucleinsäure¬ sequenzen kann dabei unter Verwendung der oben beschriebenen bekannten Nucleinsäuremoleküle oder Teile dieser Moleküle bzw. der reversen Komplemente dieser Moleküle erfolgen, z.B. mittels Hybridisierung nach Standardverfahren (siehe z.B. Sambrook et al . , a.a.O.) .Such nucleic acid sequences can be identified and isolated using the known nucleic acid molecules described above or parts of these molecules or the reverse complements of these molecules, e.g. by means of hybridization according to standard methods (see e.g. Sambrook et al., op. cit.).
Als Hybridisierungssonde können z.B. Nucleinsäuremoleküle verwendet werden, die exakt oder im wesentlichen die oben aufgeführten Nucleotidsequenzen oder Teile dieser Sequenzen aufweisen. Bei den als Hybridisierungssonde verwendeten Fragmenten kann es sich auch um synthetische Fragmente han¬ deln, die mit Hilfe der gängigen Synthesetechniken herge¬ stellt wurden und deren Sequenz im wesentlichen mit der eines bekannten Levansucrase-codierenden Nucleinsäuremole- küls übereinstimmt. Hat man Gene identifiziert und isoliert, die mit den bekannten Nucleinsäuresequenzen hybridisieren, ist eine Bestimmung der Sequenz und eine Analyse der Eigen- schaften der von dieser Sequenz codierten Proteine erforder¬ lich. Hierzu stehen dem Fachmann eine Reihe von molekular¬ biologischen, biochemischen und biotechnologischen Standard¬ verfahren zur Verfügung.For example, nucleic acid molecules can be used as the hybridization probe that have exactly or essentially the nucleotide sequences listed above or parts of these sequences. The used as a hybridization probe fragments may also be synthetic fragments spindles han ¬, HERGÉ by means of the conventional synthesizing methods and the sequence of which were ¬ represents coincides with that of a known levansucrase-encoding Nucleinsäuremole- CRWT substantially. Once genes have been identified and isolated that hybridize with the known nucleic acid sequences, a determination of the sequence and an analysis of the intrinsic The proteins encoded by this sequence are required. For this purpose, a number of standard molecular, biological, biochemical and biotechnological methods are available to the person skilled in the art.
Die mit den bekannten Nucleinsäuremolekülen hybridisierenden Moleküle umfassen auch Fragmente, Derivate und allelische Varianten der oben beschriebenen DNA-Moleküle, die eine Levansucrase codieren oder ein biologisch, d.h. enzymatisch aktives Fragment davon. Unter Fragmenten werden dabei Teile der Nucleinsäuremoleküle verstanden, die lang genug sind, um ein Polypeptid mit der enzymatischen Aktivität einer Levan¬ sucrase oder einer vergleichbaren enzymatischen Aktivität, die lokalisierten Zelltod bedingt, zu codieren. Der Ausdruck Derivat bedeutet in diesem Zusammenhang, daß die Sequenzen dieser Moleküle sich von den Sequenzen der oben beschriebe¬ nen Nucleinsäuremoleküle an einer oder mehreren Positionen unterscheiden und einen hohen Grad an Homologie zu diesen Sequenzen aufweisen. Homologie bedeutet dabei eine Sequenz- identität von mindestens 40 %, insbesondere eine Identität von mindestens 60 %, vorzugsweise über 80 % und besonders bevorzugt über 90 %. Die Abweichungen zu den oben beschrie¬ benen Nucleinsäuremolekülen können dabei durch Deletion, Ad¬ dition, Substitution, Insertion oder Rekombination entstan¬ den sein.The molecules hybridizing with the known nucleic acid molecules also include fragments, derivatives and allelic variants of the DNA molecules described above, which encode a levan sucrase or a biological, i.e. enzymatically active fragment thereof. Fragments are understood to mean parts of the nucleic acid molecules that are long enough to encode a polypeptide with the enzymatic activity of a Levan sucrase or a comparable enzymatic activity that causes localized cell death. The term derivative in this context means that the sequences of these molecules differ from the sequences of the above-described nucleic acid molecules at one or more positions and have a high degree of homology to these sequences. Homology means a sequence identity of at least 40%, in particular an identity of at least 60%, preferably over 80% and particularly preferably over 90%. The deviations from the nucleic acid molecules described above may have arisen through deletion, addition, substitution, insertion or recombination.
Homologie bedeutet ferner, daß funktioneile und/oder struk¬ turelle Äquivalenz zwischen den betreffenden Nucleinsäuremo¬ lekülen oder den durch sie codierten Proteinen besteht. Bei den Nucleinsäuremolekülen, die homolog zu den oben beschrie¬ benen Molekülen sind und Derivate dieser Moleküle darstel¬ len, handelt es sich in der Regel um Variationen dieser Mo¬ leküle, die Modifikationen darstellen, die dieselbe biologi¬ sche Funktion ausüben. Es kann sich dabei sowohl um natürli¬ cherweise auftretende Variationen handeln, beispielsweise um Sequenzen aus anderen Organismen, oder um Mutationen, wobei diese Modifikationen auf natürliche Weise aufgetreten sein können oder durch gezielte Mutagenese eingeführt wurden. Ferner kann es sich bei den Variationen um synthetisch her- gestellte Sequenzen handeln. Bei den allelischen Varianten kann es sich sowohl um natürlich auftretende als auch um synthetisch hergestellte oder durch rekombinante DNA-Techni¬ ken erzeugte Varianten handeln.Homology also means that there is functional and / or structural equivalence between the nucleic acid molecules in question or the proteins encoded by them. The nucleic acid molecules which are homologous to the molecules described above and represent derivatives of these molecules are generally variations of these molecules which represent modifications which have the same biological function. This can involve both naturally occurring variations, for example sequences from other organisms, or mutations, it being possible for these modifications to have occurred naturally or to have been introduced by targeted mutagenesis. Furthermore, the variations can be synthetic. act sequences. The allelic variants can be both naturally occurring and synthetically produced variants or those produced by recombinant DNA techniques.
Die von den verschiedenen Varianten der Nucleinsäuremoleküle codierten Proteine weisen bestimmte gemeinsame Charakteri- stika auf. Dazu können z.B. Enzymaktivität, Molekularge¬ wicht, immunologische Reaktivität, Konformation etc. gehö¬ ren. Weitere gemeinsame Charakteristika können physikalische Eigenschaften wie z.B. das Laufverhalten in Gelelektrophore¬ sen, chromatographisches Verhalten, Sedimentationskoeffizi¬ enten, Löslichkeit, spektroskopische Eigenschaften, Stabili¬ tät, pH-Optimum, Temperatur-Optimum etc. darstellen. Des weiteren können natürlich die Produkte der von den Proteinen katalysierten Reaktionen gemeinsame oder ähnliche Merkmale aufweisen. Insbesondere weisen die von den Nucleinsäurese¬ quenzen codierten Proteine Levansucrase-Aktivität auf . Der Nachweis der enzymatischen Aktivität der Levansucrase kann beispielsweise durch den Nachweis der Bildung von Levan erfolgen (vgl. Ebskamp et al . (1994) Bio/Technology 12, 272- 275) . Dieser Nachweis beruht darauf, daß sich ein Protein mit einer Levansucrase-Aktivität nachweisen läßt, wenn Pro¬ teinextrakte mit Saccharose inkubiert werden und das sich bildende Levan als Polyfructan mit Fructose-spezifischen Agentien nachgewiesen wird. Es ist gleichfalls möglich, durch Shot-Gun-Expression in z.B. E. coli bei Kultivierung auf Saccharose-haltigem Medium Levan als Polymer in situ bei Verwendung von Replikaplatten nachzuweisen.The proteins encoded by the different variants of the nucleic acid molecules have certain common characteristics. For this, e.g. Enzyme activity, molecular weight, immunological reactivity, conformation etc. belong. Other common characteristics can include physical properties such as e.g. represent the running behavior in gel electrophoresis, chromatographic behavior, sedimentation coefficients, solubility, spectroscopic properties, stability, optimum pH, optimum temperature, etc. Furthermore, the products of the reactions catalyzed by the proteins can of course have common or similar features. In particular, the proteins encoded by the nucleic acid sequences have levan sucrase activity. The detection of the enzymatic activity of levan sucrase can be carried out, for example, by the detection of the formation of levan (cf. Ebskamp et al. (1994) Bio / Technology 12, 272-275). This detection is based on the fact that a protein with a levan sucrase activity can be detected if protein extracts are incubated with sucrose and the levan which forms is detected as a polyfructan with fructose-specific agents. It is also possible to use shot gun expression in e.g. Detect E. coli when cultivated on sucrose-containing medium Levan as a polymer in situ when using replica plates.
Die erfindungsgemäßen Nucleinsäuremoleküle können beliebige Nucleinsäuremoleküle sein, insbesondere DNA- oder RNA-Mole- küle, beispielsweise cDNA, genomische DNA, mRNA etc. Sie können natürlich vorkommende oder durch gentechnische oder chemische Syntheseverfahren hergestellte Moleküle sein.The nucleic acid molecules according to the invention can be any nucleic acid molecules, in particular DNA or RNA molecules, for example cDNA, genomic DNA, mRNA etc. They can be naturally occurring molecules or those produced by genetic engineering or chemical synthesis methods.
Erfindungsgemäß sind die Nucleinsäuremoleküle der vorliegen¬ den Erfindung mit regulatorischen Elementen verknüpft, die die Transkription und Translation in der Pflanzenzelle ge¬ währleisten. Durch die Bereitstellung der erfindungsgemäßen Nucleinsäuremoleküle besteht nun die Möglichkeit, pflanzli¬ che Zellen mittels gentechnologischer Methoden dahingehend zu verändern, daß sie eine, einen lokalen Zelltod bewirkende enzymatische Aktivität aufweisen.According to the invention the nucleic acid molecules are present ¬ the invention to regulatory elements linked to the ensure transcription and translation in the plant cell. By providing the nucleic acid molecules according to the invention, there is now the possibility of changing plant cells by means of genetic engineering methods to the effect that they have an enzymatic activity which causes local cell death.
Ein besonderer Vorteil der Erfindung besteht darin, daß der lokale Zelltod in Pflanzen unter Verwendung der erfindungs¬ gemäßen Nucleinsäuremoleküle gegebenenfalls gezielt ausge¬ löst werden kann. Für den genannten Promotor kommt daher im Prinzip jeder in den für die Transformation gewählten Pflan¬ zen funktionale Promotor in Betracht, der die Bedingung er¬ füllt, daß die von ihm regulierte Expression zu einer loka¬ lisierten Nekrose führt und die Pflanze nicht zu großflächig zum Absterben bringt. Besonders sinnvoll erscheinen hierfür Promotoren, die spezifisch bei Befall durch Pathogene lokal induziert werden. Dabei schließt der Begriff Pathogen im Rahmen der vorliegenden Erfindung Pilze, Bakterien, Viren, Insekten sowie Nematoden ein. Solche Promotoren sind bekannt und in der Literatur beschrieben, vgl. z.B. Martini et al . (1993) Molecular and General Genetics 236, 179-186, oder WO 94/17194. Wenn solche Promotoren nicht bekannt sind, so ist das Konzept zur Isolierung solcher Promotoren dem Fachmann bekannt. Dabei wird in einem ersten Schritt aus einem Ge¬ webe, welches von einem bestimmten Pathogen befallen ist, die poly(a)+ RNA isoliert und eine cDNA-Bank angelegt. In einem zweiten Schritt werden mit Hilfe von cDNA-Clonen, die auf poly(A)+ RNA-Molekülen aus einem nicht-infizierten Ge¬ webe basieren, aus der ersten Bank mittels Hybridisierung diejenigen Clone identifiziert, deren korrespondierende poly(A)+ RNA-Moleküle lediglich bei Befall durch das Patho¬ gen induziert werden. Anschließend werden mit Hilfe dieser so identifizierten cDNA's Promotoren isoliert, die sodann für die Expression der hier beschriebenen codierenden Nucleinsäuresequenzen verwendet werden können. In einer be¬ vorzugten Ausführungsform steht die Nucleinsäuresequenz, die die den lokalen Zelltod verantwortliche enzymatische Aktivi- tat codiert, daher unter der Kontrolle eines pathogen-indu- zierten Promotors. In einer besonders bevorzugten Ausgestal¬ tung liegt die Nucleinsäuresequenz in Kombination mit dem prpl-1-Promotor aus Kartoffel vor.A particular advantage of the invention is that local cell death in plants can optionally be triggered in a targeted manner using the nucleic acid molecules according to the invention. In principle, any promoter which is functional in the plants selected for the transformation and which fulfills the condition that the expression regulated by it leads to localized necrosis and that the plant does not become too large is suitable for the promoter mentioned Dying brings. Promoters which are specifically induced locally when infected by pathogens appear to be particularly useful for this purpose. The term pathogen in the context of the present invention includes fungi, bacteria, viruses, insects and nematodes. Such promoters are known and described in the literature, cf. eg Martini et al. (1993) Molecular and General Genetics 236, 179-186, or WO 94/17194. If such promoters are not known, the concept of isolating such promoters is known to the person skilled in the art. In a first step, the poly (a) + RNA is isolated from a tissue infected with a specific pathogen and a cDNA library is created. In a second step, cDNA clones based on poly (A) + RNA molecules from a non-infected tissue are used to identify those clones from the first bank whose hybrid poly (A) + RNA is used -Molecules are only induced when the pathogen is infected. Promoters are then isolated with the help of these cDNAs identified in this way, which can then be used for the expression of the coding nucleic acid sequences described here. In a preferred embodiment there is the nucleic acid sequence which the enzymatic activations responsible for the local cell death tat coded, therefore under the control of a pathogen-induced promoter. In a particularly preferred embodiment, the nucleic acid sequence is in combination with the potato prpl-1 promoter.
Weitere bevorzugte Ausführungsformen umfassen die Kombina¬ tion der für den Zelltod verantwortlichen Nucleinsäurese¬ quenz mit in Pflanzen aktiven gewebe- oder entwicklungsspe¬ zifischen Promotoren. Besonders bevorzugt ist ein Nuclein- säuremolekül, in dem die codierende Nucleinsäuresequenz unter Kontrolle eines antheren- oder tapetumspezifischen Promotors steht.Further preferred embodiments include the combination of the nucleic acid sequence responsible for cell death with tissue-specific or development-specific promoters active in plants. A nucleic acid molecule in which the coding nucleic acid sequence is under the control of an anther- or tapetum-specific promoter is particularly preferred.
Eine Alternative zur Erreichung des Ziels, daß die Pflanze in vielen Bereichen aufgrund der Expression der erfindungs¬ gemäßen Nucleinsäuremoleküle einen lokalisierten Zelltod aufweist, besteht darin, einen konstitutiven Promotor zu verwenden, diesen Promotor aber von der codierenden Sequenz der erfindungsgemäßen Nucleinsäuremoleküle durch die Inser- tion eines transposablen Elements (Transposon) zu trennen. Von Transposons ist bekannt, daß sie in somatischen Geweben exzisieren. Solche Exzisionen führen dazu, daß Promotor und codierende Sequenz in direkten Kontakt gebracht werden und führen somit zur Bildung der für den lokalisierten Zelltod verantwortlichen enzymatischen Aktivität. Transposons sind in der Literatur beschrieben und cloniert und stehen in rei¬ cher Auswahl zur Verfügung, wie z.B. Ac/Ds (Aktivator/Dis- soziation-Transposonfamilie) , En/Spm aus Mais (Enhancer/Sup- pressor-mutator-Transposonfamilie; vgl. Düring and Sarlinger (1986) Ann. Rev. Genet . 20, 175 für eine Übersicht) .An alternative to achieving the goal that the plant has localized cell death in many areas due to the expression of the nucleic acid molecules according to the invention is to use a constitutive promoter, but this promoter from the coding sequence of the nucleic acid molecules according to the invention by insertion to separate a transposable element (transposon). Transposons are known to excite in somatic tissues. Such excisions result in the promoter and coding sequence being brought into direct contact and thus lead to the formation of the enzymatic activity responsible for the localized cell death. Transposons are described and cloned in the literature and are available in a wide range, e.g. Ac / Ds (activator / dissociation transposon family), En / Spm from maize (enhancer / suppressor mutator transposon family; see Düring and Sarlinger (1986) Ann. Rev. Genet. 20, 175 for an overview) .
Die Verwendung der erfindungsgemäßen Nucleinsäuremoleküle zur Erzeugung eines lokalen Zelltodes kann neben der be¬ schriebenen Anwendung zur Erzeugung einer systemisch erwor¬ benen Resistenz (SAR) gegenüber Pathogenen und somit zur Er¬ zeugung von Pflanzen, die sich durch eine erhöhte Krank¬ heitsresistenz auszeichnen, auch zur Erzeugung von männlich sterilen Pflanzen genutzt werden. Männlich sterile Pflanzen spielen in der Pflanzenzüchtung, insbesondere in der Hybrid¬ züchtung, eine bedeutende Rolle. Zu diesem Zweck wird die für die den Zelltod verursachende enzymatische Aktivität co¬ dierende Nucleinsäuresequenz mit einem antheren- oder tape- tumspezischen Promotor gekoppelte. Beispiele für solche Pro¬ motoren werden z.B. in W092/13956 und W092/13957 genannt. Dies führt zum Absterben der Antheren und damit zur Unter¬ bindung der Pollenbildung. Ein Restorer-Gen, das mit der er¬ findungsgemäßen Nucleinsäuresequenz gemeinsam verwendet wer¬ den kann, würde die den Zelltod bewirkende enzymatische Ak¬ tivität unterdrücken. So würde z.B. bei der Verwendung der eine Levansucrase codierenden Region die Bildung des Pro¬ dukts, dies bedeutet des Levans, durch eine gleichzeitige Expression einer Levanase im Zellraum beeinflußt werden. Al¬ ternativ würde die Expression eines entsprechenden Anti- sense-Konstrukts die den lokalisierten Zelltod verursachende enzymatische Aktivität aufgrund einer Antisense-Suppression beeinflussen. Ebenso könnte die Expression der erfindungsge- mäßen Nucleinsäuremoleküle und damit die daraus resultie¬ rende zeiltötende Aktivität durch das Phänomen der Cosup- pression durch das zusätzliche Einbringen von sense-Kon- strukten in die Pflanzenzelle beeinflußt werden.The use of the nucleic acid molecules according to the invention for generating a local cell death can in addition to the be¬ signed application to generate a systemic erwor ¬ surrounded resistance (SAR) to pathogens and thus to He ¬ generation of plants, the integrated resistance by an increased Krank¬ distinguished, even for the production of male sterile plants can be used. Male sterile plants play an important role in plant breeding, especially in hybrid breeding. For this purpose, the nucleic acid sequence coding for the enzymatic activity causing the cell death is coupled with an anther- or tape-specific promoter. Examples of such motors are mentioned, for example, in W092 / 13956 and W092 / 13957. This leads to the death of the anthers and the sub ¬ connection pollen formation. A restorer gene, which can be used together with the nucleic acid sequence according to the invention, would suppress the enzymatic activity causing the cell death. For example, if the region encoding a levan sucrase were used, the formation of the product, ie the levan, would be influenced by a simultaneous expression of a levanase in the cell space. Alternatively, the expression of a corresponding antisense construct would influence the enzymatic activity causing the localized cell death due to antisense suppression. Likewise, the expression of the nucleic acid molecules according to the invention and thus the resulting cell-killing activity could be influenced by the phenomenon of cosuppression by the additional introduction of sense constructs into the plant cell.
Des weiteren können die erfindungsgemäßen Nucleinsäurese¬ quenzen zusammen mit Promotoren verwendet werden, die in Pflanzen durch abiotische Stimuli, wie z.B. Chemikalien, Ozon, UV-Strahlung, extreme Temperaturen, Trockenheit, Salz induziert werden. Beispiele für solche Promotoren finden sich in der Literatur, so z.B. in Williams et al . (1992) Biotechnology 10, 540.Furthermore, the nucleic acid sequences according to the invention can be used together with promoters which are induced in plants by abiotic stimuli, e.g. Chemicals, ozone, UV radiation, extreme temperatures, drought, salt can be induced. Examples of such promoters can be found in the literature, e.g. in Williams et al. (1992) Biotechnology 10, 540.
Es besteht grundsätzlich die Möglichkeit, daß die für den lokalen Zelltod verantwortliche enzymatische Aktivität in jedem beliebigen Kompartiment der pflanzlichen Zelle lokali¬ siert sein kann. In einer bevorzugten Ausführungsform wird die Form des Proteins, oder eines Fragments davon gewählt, die im extrazellulären Raum, d.h. im Apoplast, lokalisiert ist . In einer besonders bevorzugten Ausführungsform wird die codierende Sequenz der Levansucrase verwendet, wie sie aus Erwinia amylovora isoliert worden ist.There is basically the possibility that the enzymatic activity responsible for local cell death can be localized in any compartment of the plant cell. In a preferred embodiment, the shape of the protein or a fragment thereof is selected which is localized in the extracellular space, ie in the apoplast. In a particularly preferred embodiment, the coding sequence of levansucrase is used, as has been isolated from Erwinia amylovora.
In einer weiteren bevorzugten Ausführungsform enthält das erfindungsgemäße Nucleinsäuremolekül ein Terminationssignal für die Termination der Transkription und die Addition eines Poly-A-Schwanzes an das entsprechende Transkript. Derartige Terminationssignale sind bekannt und sind beliebig gegenein¬ ander austauschbar. Ein Beispiel für eine solche Sequenz ist das Terminationssignal des Octopin-Synthase-Gens von Agro- bacterium tumefaciens.In a further preferred embodiment, the nucleic acid molecule according to the invention contains a termination signal for the termination of the transcription and the addition of a poly-A tail to the corresponding transcript. Such termination signals are known and can be interchanged with one another as desired. An example of such a sequence is the termination signal of the octopine synthase gene from Agrobacterium tumefaciens.
Gegebenenfalls können die Nucleinsäuresequenzen der Erfin¬ dung durch Enhancer-Sequenzen oder andere regulatorische Se¬ quenzen ergänzt sein. Diese regulatorischen Sequenzen umfas¬ sen z.B. auch Signalsequenzen, die für den Transport des Genprodukts zu einem bestimmten Kompartiment sorgen. Vor¬ zugsweise umfaßt ein erfindungsgemäßes Nucleinsäuremolekül eine Nucleotidsequenz, die eine die Sekretion des Proteins gewährleistende Aminosäuresequenz codiert .Optionally, the nucleic acid sequences of the invention can be supplemented by enhancer sequences or other regulatory sequences. These regulatory sequences include e.g. also signal sequences that ensure that the gene product is transported to a specific compartment. A nucleic acid molecule according to the invention preferably comprises a nucleotide sequence which codes an amino acid sequence which ensures the secretion of the protein.
Die vorliegende Erfindung betrifft ferner Vektoren, insbe¬ sondere Plasmide, Cosmide, Viren Bakteriophagen und andere in der Gentechnik gängige Vektoren, die die oben beschriebe¬ nen erfindungsgemäßen Nucleinsäuremoleküle enthalten und ge¬ gebenenfalls für den Transfer der erfindungsgemäßen Nuclein¬ säuremoleküle in Pflanzen bzw. Pflanzenzellen eingesetzt werden können.The present invention further relates to vectors, in particular plasmids, cosmids, viruses, bacteriophages and other vectors common in genetic engineering, which contain the above-described nucleic acid molecules according to the invention and, if appropriate, for the transfer of the nucleic acid molecules according to the invention into plants or plant cells can be used.
Ebenso betrifft die Erfindung Wirtszellen, die mit einem er¬ findungsgemäßen Nucleinsäuremolekül oder Vektor gentechnisch modifiziert sind. Dieses können prokaryontische als auch eukaryontische Zellen sein. Insbesondere können es Mikroor¬ ganismen sein, wie Bakterien, Viren, Pilze, die die erfin¬ dungsgemäßen Nucleinsäuresequenzen enthalten, d.h. Mikroor- ganismen, die mit einem erfindungsgemäßen Nucleinsäuremole¬ kül genetisch modifiziert sind. Ferner können es auch tie¬ rische Zellen sein.The invention also relates to host cells which are genetically modified with a nucleic acid molecule or vector according to the invention. These can be prokaryotic as well as eukaryotic cells. In particular, it may be Mikroor ¬ organisms, such as bacteria, viruses, fungi containing the OF INVENTION ¬ to the invention nucleic acid sequences, that Mikroor- ganisms that are genetically modified with a nucleic acid molecule according to the invention. In addition, it can also tie ¬ generic cells.
Durch die Bereitstellung der erfindungsgemäßen Nucleinsäure¬ moleküle besteht nun die Möglichkeit, pflanzliche Zellen mittels gentechnischer Methoden dahingehend zu verändern, daß sie im Vergleich zu Wildtypzellen eine neue enzymatische Aktivität aufweisen, und es als Folge davon in Pflanzen, die derartige Zellen enthalten, zu einem lokalen Zelltod kommen kann.By providing the nucleic acid molecules according to the invention, there is now the possibility, using genetic engineering methods, to modify plant cells to the extent that they have a new enzymatic activity compared to wild-type cells and, as a result, to localize in plants which contain such cells Cell death can come.
In einer bevorzugten Ausführungsform handelt es sich daher bei den erfindungsgemäßen Wirtszellen um pflanzliche Zellen, die aufgrund der Gegenwart und Expression eines zusätzlich eingeführten erfindungsgemäßen Nucleinsäuremoleküls im Ver¬ gleich zu nicht-transformierten Zellen eine enzymatische Ak¬ tivität aufweisen, die für einen lokalen Zelltod verantwort¬ lich ist. In einer besonders bevorzugten Ausführungsform handelt es sich um transgene pflanzliche Zellen, die eine Levansucrase exprimieren unter der Kontrolle eines pathogen- spezifischen Promotors.In a preferred embodiment, the host cells according to the invention are plant cells which, owing to the presence and expression of an additionally introduced nucleic acid molecule according to the invention, have an enzymatic activity in comparison to non-transformed cells which is responsible for local cell death is. In a particularly preferred embodiment, these are transgenic plant cells which express a levan sucrase under the control of a pathogen-specific promoter.
Das erfindungsgemäße Nucleinsäuremolekül kann dabei stabil in das Genom der Pflanzenzelle integriert sein. Alternativ kann das Nucleinsäuremolekül, das die den Zelltod bedingende enzymatische Aktivität codiert, als selbstreplizierendes System in die Zelle eingebracht werden.The nucleic acid molecule according to the invention can be stably integrated into the genome of the plant cell. Alternatively, the nucleic acid molecule encoding the enzymatic activity that causes cell death can be introduced into the cell as a self-replicating system.
Gegenstand der Erfindung sind ebenfalls transgene Pflanzen, die die oben beschriebenen erfindungsgemäßen transgenen Pflanzenzellen, in denen die Nucleinsäuremoleküle integriert in das pflanzliche Genom vorliegen, enthalten. Ebenfalls Ge¬ genstand der Erfindung sind Pflanzen, in deren Zellen ein erfindungsgemäßes Nucleinsäuremolekül in selbstreplizieren¬ der Form vorliegt, d.h. die Pflanzenzelle enthält die fremde DNA auf einem eigenständigen Nucleinsäuremolekül. Bei den Pflanzen, die mit den erfindungsgemäßen Nucleinsäu¬ remolekülen transformiert sind und in denen aufgrund der Einführung eines solchen Moleküls ein für einen lokalisier¬ ten Zelltod verantwortliches Protein synthetisiert wird, kann es sich im Prinzip um jede beliebige Pflanze handeln. Vorzugsweise ist es eine monokotyle oder dikotyle Nutz¬ pflanze. Beispiele für monokotyle Pflanzen sind die Pflan¬ zen, die zu den Gattungen Avena (Hafer) , Triticum (Weizen) , Seeale (Roggen) , Hordeum (Gerste) , Oryza (Reis) , Panicum, Pennisetum, Setaria, Sorghum (Hirse) , Zea (Mais) gehören. Bei den dicotylen Nutzpflanzen sind u.a. zu nennen Baum¬ wolle, Leguminosen, wie Hülsenfrüchte und insbesondere Alfalfa, Sojabohne, Raps, Tomate, Zuckerrübe, Kartoffel, Zierpflanzen, Bäume. Weitere Nutzpflanzen können Obst (ins¬ besondere Äpfel, Birnen, Kirschen, Weintrauben, Citrus, Ana¬ nas und Bananen) , Ölpalmen, Tee-, Kakao- und Kaffeesträu- cher, Tabak, Sisal sowie bei Heilpflanzen Rauwolfia und Di¬ gitalis sein. Besonders bevorzugt sind die Getreide, Weizen, Roggen, Hafer, Gerste, Reis, Mais und Hirse, Zuckerrübe, Raps, Soja, Tomate und Kartoffel.The invention also relates to transgenic plants which contain the transgenic plant cells according to the invention described above, in which the nucleic acid molecules are integrated into the plant genome. Plants are also the subject of the invention, in the cells of which a nucleic acid molecule according to the invention is present in self-replicating form, ie the plant cell contains the foreign DNA on an independent nucleic acid molecule. The plants which are transformed with the nucleic acid molecules according to the invention and in which a protein responsible for localized cell death is synthesized due to the introduction of such a molecule can in principle be any plant. It is preferably a monocotyledon or dicotyledon crop. Examples of monocot plants are the plants belonging to the genera Avena (oats), Triticum (wheat), Seeale (rye), Hordeum (barley), Oryza (rice), Panicum, Pennisetum, Setaria, Sorghum (millet), Zea (corn) belong. In the case of the dicotyledonous crops, cotton, legumes, such as legumes and in particular alfalfa, soybean, rapeseed, tomato, sugar beet, potato, ornamental plants, trees are to be mentioned among others. Other useful plants can be fruit (in particular apples, pears, cherries, grapes, citrus, ananas and bananas), oil palms, tea, cocoa and coffee bushes, tobacco, sisal and, in the case of medicinal plants, rauwolfia and digitalis. Cereals, wheat, rye, oats, barley, rice, corn and millet, sugar beet, rapeseed, soy, tomato and potato are particularly preferred.
Gegenstand der Erfindung ist ferner Vermehrungsmaterial von erfindungsgemäßen Pflanzen, beispielsweise Samen, Früchte, Stecklinge, Knollen, Wurzelstöcke etc., wobei dieses Vermeh¬ rungsmaterial oben beschriebene transgene Pflanzenzellen enthält. Ebenso betrifft die vorliegende Erfindung Teile der erfindungsgemäßen Pflanzen, wie z.B. Protoplasten, Pflanzen¬ zelle und Kalli, die erfindungsgemäße Nucleinsäuremoleküle enthalten.The invention furthermore relates to propagation material from plants according to the invention, for example seeds, fruits, cuttings, tubers, rhizomes etc., this propagation material containing transgenic plant cells described above. The present invention also relates to parts of the plants according to the invention, such as e.g. Protoplasts, plant cells and calli that contain nucleic acid molecules according to the invention.
Die Erfindung betrifft ebenfalls Pflanzen, die aufgrund der Expression der erfindungsgemäßen Nucleinsäuremoleküle eine im Vergleich zu Pflanzen, die die Nucleinsäuremoleküle nicht enthalten, erhöhte Salicylsäurekonzentration aufweisen. Wei¬ ter betrifft die Erfindung Pflanzen, die sich im Vergleich zu Pflanzen, die die erfindungsgemäßen Nucleinsäuremoleküle nicht enthalten, durch eine erhöhte Krankheitsresistenz aus¬ zeichnen.The invention also relates to plants which, owing to the expression of the nucleic acid molecules according to the invention, have an increased salicylic acid concentration in comparison to plants which do not contain the nucleic acid molecules. The invention further relates to plants which, in comparison to plants, contain the nucleic acid molecules according to the invention not included, characterized by increased disease resistance.
In einer besonders bevorzugten Ausführungsform handelt es sich um Pflanzen, die aufgrund der Expression eines Levan- sucrase-Gens aus E. amylovora einen lokalen Zelltod zeigen, der gegebenenfalls mit der Ausprägung einer SAR einhergeht .In a particularly preferred embodiment, these are plants which, owing to the expression of a levan sucrase gene from E. amylovora, show local cell death which may be associated with the expression of a SAR.
Die vorliegende Erfindung betrifft ebenfalls Pflanzen, die durch die Expression eines erfindungsgemäßen Nucleinsäuremo- leküls männlich steril sind.The present invention also relates to plants which are male-sterile due to the expression of a nucleic acid molecule according to the invention.
Weiterhin betrifft die vorliegende Erfindung ein Verfahren, mit dessen Hilfe die Erzeugung von Pflanzen, die einen loka¬ lisierten Zelltod zeigen und die gegebenenfalls zusätzlich durch den Erwerb einer SAR gekennzeichnet sind, sowie von Pflanzen, die aufgrund des lokalisierten Zelltods männlich steril sind, möglich ist.Furthermore, the present invention relates to a method by means of which it is possible to produce plants which show a localized cell death and which may additionally be characterized by the acquisition of an SAR, and plants which are male-sterile due to the localized cell death .
Zur Erzeugung solcher Pflanzen bieten sich verschiedene Me¬ thoden an. Zum einen können Pflanzen bzw. Pflanzenzellen mit Hilfe hermömmlicher gentechnologischer Transformationsmetho¬ den derart verändert werden, daß ein erfindungsgemäßes Nucleinsäuremolekül in das pflanzliche Genom integriert wird, d.h. daß stabile Transformanten erzeugt werden. Zum anderen kann ein erfindungsgemäßes Nucleinsäuremolekül, des¬ sen Expression in der Pflanzenzelle das Absterben der Zelle bewirkt, in der Pflanzenzelle bzw. der Pflanze als selbstre¬ plizierendes System enthalten sein. So können die erfin¬ dungsgemäßen Nucleinsäuremoleküle z.B. in einem Virus ent¬ halten sein, mit dem die Pflanze bzw. Pflanzenzelle in Kon¬ takt kommt .Various methods are available for producing such plants. On the one hand, plants or plant cells can be modified with the aid of conventional genetic engineering transformation methods such that a nucleic acid molecule according to the invention is integrated into the plant genome, i.e. that stable transformants are generated. On the other hand, a nucleic acid molecule according to the invention, the expression of which in the plant cell causes the cell to die, can be contained in the plant cell or the plant as a self-replicating system. Thus the nucleic acid molecules according to the invention can e.g. be contained in a virus with which the plant or plant cell comes into contact.
Erfindungsgemäß werden Pflanzenzellen, die aufgrund der Ex¬ pression eines erfindungsgemäßen Nucleinsäuremoleküls eine einen Zelltod bewirkende Aktivität besitzen, durch ein Ver¬ fahren hergestellt, das folgende Schritte umfaßt: (a) Herstellung einer Expressionskassette , die folgende Se¬ quenzen umfaßt :According to the invention, plant cells which have an activity causing cell death due to the expression of a nucleic acid molecule according to the invention are produced by a process which comprises the following steps: (a) Production of an expression cassette which comprises the following sequences:
- einen Promotor, der die Transkription in pflanzlichen Zellen gewährleistet;- a promoter that ensures transcription in plant cells;
- mindestens eine Nucleinsäuresequenz, die ein Protein oder ein Fragment davon codiert, dessen enzymatische Aktivität in Pflanzen einen lokalisierten Zelltod be¬ wirkt, wobei die Nucleinsäuresequenz in sense-Orien- tierung an das 3 ' -Ende des Promotors gekoppelt ist; undat least one nucleic acid sequence which encodes a protein or a fragment thereof, the enzymatic activity of which causes localized cell death in plants, the nucleic acid sequence being coupled in sense orientation to the 3 'end of the promoter; and
- gegebenenfalls ein Terminationssignal für die Termina- tion der Transkription und die Addition eines poly-A- Schwanzes an das entsprechende Transkript, das an das 3 ' -Ende der codierenden Region gekoppelt ist .- if necessary, a termination signal for the termination of the transcription and the addition of a poly-A tail to the corresponding transcript which is coupled to the 3 'end of the coding region.
(b) Transformation pflanzlicher Zellen mit der in Schritt(b) Transformation of plant cells with that in step
(a) hergestellten Expressionskassette.(a) manufactured expression cassette.
(c) Regeneration transgener Pflanzen und gegebenenfalls die Vermehrung der Pflanzen.(c) Regeneration of transgenic plants and, if appropriate, the multiplication of the plants.
Alternativ können ein oder mehrere erfindungsgemäße Nuclein¬ säuremoleküle als selbstreplizierendes System in die Pflan¬ zenzelle bzw. Pflanze eingebracht werden.Alternatively, one or more nucleic acid molecules according to the invention can as a self-replicating system in ¬ These crops zenzelle or plant are introduced.
Gegenstand der Erfindung ist ebenfalls die Verwendung eines pathogen-spezifischen Promotors, insbesondere des prpl-1- Promotors zur Erzeugung von Pflanzen, bei denen ein lokali¬ sierter Zelltod auftritt und/oder die mindestens ein für eine systemisch erworbene Resistenz typisches Merkmal und/oder erhöhte Krankheitsresistenz im Vergleich zu Wild¬ typ-Pflanzen aufweisen.The invention is also the use of a pathogen-specific promoter, in particular the prpl-1 promoter for the production of plants in which a cell death occurs lokali ¬ lized and / or the at least one typical for a systemic acquired resistance trait and / or increased Have disease resistance compared to wild ¬ type plants.
Die Erfindung betrifft ebenfalls die Verwendung von Nuclein¬ säuresequenzen, die ein Protein mit der enzymatischen Akti¬ vität einer Levansucrase codieren, zur Erzeugung von Pflan- zen, die sich durch einen lokalisierten Zelltod auszeichnen, sowie zur Erzeugung eines lokalisierten Zelltods in Pflan¬ zen. Ebenso betrifft die vorliegende Erfindung die Verwen¬ dung derartiger Nucleinsäuresequenzen zur Erzeugung einer systemisch erworbenen Resistenz bei Pflanzen, zur Erhöhung der Salicylsäure-Konzentration in Pflanzen und/oder zur Er¬ höhung der Krankheitsresistenz in Pflanzen.The invention also relates to the use of nucleic acid sequences ¬ that tivity a protein having the enzymatic Akti ¬ a levansucrase encode for generating of plant zen, which are characterized by a localized cell death, as well as for the production of a localized cell death in plants. Also, the present invention relates to the Verwen¬ dung such nucleic acid to produce a systemic acquired resistance in plants, to increase the salicylic acid concentration in plants and / or He ¬ disease resistance heightening in plants.
Weiter betrifft die Erfindung die Verwendung eines Proteins mit der enzymatischen Aktivität einer Levansucrase, um in Pflanzen einen lokalisierten Zelltod hervorzurufen.The invention further relates to the use of a protein with the enzymatic activity of a levan sucrase in order to cause localized cell death in plants.
Die vorliegende Erfindung betrifft ebenso die Verwendung von Nucleinsäuresequenzen, die Proteine mit der biologischen Ak¬ tivität einer Levansucrase codieren, oder solcher Proteine, zur Erzeugung von männlicher Sterilität in Pflanzen.The present invention also relates to the use of nucleic acid sequences which encode proteins with the biological activity of a levan sucrase, or such proteins, for producing male sterility in plants.
Die vorliegende Erfindung umfaßt somit jede mögliche Form des Einsatzes der erfindungsgemäßen Nucleinsäuremoleküle, deren Expression in Pflanzen das Absterben von Zellen be¬ wirkt, sowie des Einsatzes der erfindungsgemäßen Proteine oder Fragmente davon, deren enzymatische Aktivität den Zell¬ tod herbeiführen.The present invention thus encompasses every possible form of use of the nucleic acid molecules according to the invention, the expression of which in plants causes the death of cells, and of the proteins or fragments thereof according to the invention, the enzymatic activity of which causes cell death.
Zur Vorbereitung der Einführung fremder Gene in höhere Pflanzen stehen eine große Anzahl von Clonierungsvektoren zur Verfügung, die ein Replikationssignal for E. coli und ein Markergen zur Selektion transformierter Bakterienzellen enthalten. Beispiele für derartige Vektoren sind pBR322, pUC-Serien, M13mp-Serien, paCYC184 usw. Die gewünschte Se¬ quenz kann an einer passenden Restriktionsschnittstelle in den Vektor eingeführt werden. Das erhaltene Plasmid wird für die Transformation von E. coli-Zellen verwendet. Transfor¬ mierte E. coli-Zellen werden in einem geeigneten Medium ge¬ züchtet und anschließend geerntet und lysiert. Das Plasmid wird wiedergewonnen. Als Analysemethode zur Charakterisie¬ rung der gewonnenen Plasmid-DNA werden im allgemeinen Re- striktionsanalysen, Gelelektrophoresen und weitere bioche- misch-molekularbiologische Methoden eingesetzt. Nach jeder Manipulation kann die Plasmid-DNA gespalten werden und die gewonnenen DNA-Fragmente können mit anderen DNA-Sequenzen verknüpft werden. Jede Plasmid-DNA-Sequenz kann in den glei¬ chen oder anderen Plasmiden cloniert werden.To prepare the introduction of foreign genes into higher plants, a large number of cloning vectors are available which contain a replication signal for E. coli and a marker gene for the selection of transformed bacterial cells. Examples of such vectors are pBR322, pUC series, M13mp series, paCYC184 etc. The desired sequence can be introduced into the vector at a suitable restriction interface. The plasmid obtained is used for the transformation of E. coli cells. Transformed E. coli cells are grown in a suitable medium and then harvested and lysed. The plasmid is recovered. As analysis method for characterizing the plasmid DNA obtained, generally restriction analyzes, gel electrophoresis and other biochemical-molecular biological methods are used. After each manipulation, the plasmid DNA can be cleaved and the DNA fragments obtained can be linked to other DNA sequences. Each plasmid DNA sequence can be cloned into the same or other plasmids.
Für die Einführung von DNA in eine pflanzliche Wirtszelle stehen eine Vielzahl bekannter Techniken zur Verfügung, wo¬ bei der Fachmann die jeweils geeignete Methode ohne Schwie¬ rigkeiten ermitteln kann. Diese Techniken umfassen die Transformation pflanzlicher Zellen mit T-DNA unter Verwen¬ dung von Agrobacterium tumefaciens oder Agrobacterium rhizo- genes als Transformationsmittel, die Fusion von Protopla¬ sten, den direkten Gentransfer isolierter DNA in Protopla¬ sten, die Elektroporation von DNA, die Einbringung von DNA mittels der biolistischen Methode sowie weitere Möglichkei¬ ten. Alternativ können die erfindungsgemäßen Nucleinsäuremo¬ leküle, z.B. über eine virale Infektion, als selbstreplizie¬ rendes System ohne nachfolgende Integration in das pflanzli¬ che Genom in die Zellen eingebracht werden.A large number of known techniques are available for introducing DNA into a plant host cell, and the person skilled in the art can determine the appropriate method in each case without difficulty. These techniques include the transformation of plant cells with T-DNA using Agrobacterium tumefaciens or Agrobacterium rhizogenes as transformation agents, the fusion of protoplasts, the direct gene transfer of isolated DNA into protoplasts, the electroporation of DNA, the introduction of DNA by means of the biolistic method and other possibilities. Alternatively, the nucleic acid molecules according to the invention, for example can be introduced into the cells via a viral infection as a self-replicating system without subsequent integration into the plant genome.
Bei der Injektion und Elektroporation von DNA in Pflanzen¬ zellen werden per se keine speziellen Anforderungen an die verwendeten Plasmide gestellt. Ähnliches gilt für den direk¬ ten Gentransfer. Es können einfache Plasmide wie z.B. pUC- Derivate verwendet werden. Sollen aber aus derartig trans¬ formierten Zellen ganze Pflanzen regeneriert werden, so sollte ein selektierbares Markergen anwesend sein. Dem Fach¬ mann sind die gängigen Selektionsmarker bekannt und es stellt für ihn kein Problem dar, einen geeigneten Marker auszuwählen.In the injection and electroporation of DNA into plant cells, no special requirements are made of the plasmids used per se. The same applies to direct gene transfer. Simple plasmids such as e.g. pUC derivatives are used. However, if whole plants are to be regenerated from such transformed cells, a selectable marker gene should be present. The conventional selection markers are known to the person skilled in the art and it is not a problem for him to select a suitable marker.
Je nach Einführungsmethode eines Gens in die Pflanzenzelle können gebebenenfalls weitere DNA-Sequenzen erforderlich sein. Werden z.B. für die Transformation der Pflanzenzelle das Ti- oder Ri-Plasmid verwendet, so sollte mindestens die rechte Begrenzung, häufig jedoch die rechte und linke Be¬ grenzung der im Ti- und Ri-Plasmid enthaltenen T-DNA als Flankenbereich mit den einzuführenden Genen verbunden wer¬ den.Depending on the method of introducing a gene into the plant cell, additional DNA sequences may be required. If, for example, the Ti or Ri plasmid is used for transformation of the plant cell, it should be at least the right border, but often the right and left Be ¬ limitation of the T-DNA contained in the Ti- and Ri-plasmid as Flanking region to the genes to be introduced linked to ¬.
Werden für die Transformation Agrobakterien verwendet, sollte die einzuführende DNA in spezielle Plasmide cloniert werden, und zwar entweder in einen intermediären oder in einen binären Vektor. Die intermediären Vektoren können auf¬ grund von Sequenzen, die homolog zu Sequenzen in der T-DNA sind, durch homologe Rekombination in das Ti- oder Ri-Plas¬ mid der Agrobakterien integriert werden. Dieses enthält außerdem die für den Transfer der T-DNA notwendige vir-Re- gion. Intermediäre Vektoren können nicht in Agrobakterien replizieren. Mittels eines Helferplasmids kann der interme¬ diäre Vektor auf Agrobacterium tumefaciens übertragen werdenIf agrobacteria are used for the transformation, the DNA to be introduced should be cloned into special plasmids, either in an intermediate or in a binary vector. The intermediate vectors can on ¬ Due to sequences that are homologous to sequences in the T-DNA by homologous recombination into the Ti or Ri-Plas¬ the Agrobacteria mid be integrated. This also contains the vir region necessary for the transfer of the T-DNA. Intermediate vectors cannot replicate in agrobacteria. The intermediate vector can be transferred to Agrobacterium tumefaciens by means of a helper plasmid
(Konjugation) . Binäre Vektoren können sowohl in E. coli als auch in Agrobakterien replizieren. Sie enthalten ein Selek- tionsmarker-Gen und einen Linker oder Polylinker, welche von der rechten und linken T-DNA-Grenzregion eingerahmt werden. Sie können direkt in die Agrobakterien transformiert werden(Conjugation). Binary vectors can replicate in E. coli as well as in Agrobacteria. They contain a selection marker gene and a linker or polylinker, which are framed by the right and left T-DNA border region. They can be transformed directly into the agrobacteria
(Holsters et al . (1978) Molecular and General Genetics 163, 181-187) . Das als Wirtszelle dienende Agrobacterium sollte ein Plasmid, das eine vir-Region trägt, enthalten. Die vir- Region ist in der Regel für den Transfer der T-DNA in die Pflanzenzelle notwendig. Zusätzliche T-DNA kann vorhanden sein.(Holsters et al. (1978) Molecular and General Genetics 163, 181-187). The Agrobacterium serving as the host cell should contain a plasmid which carries a vir region. The vir region is usually necessary for the transfer of the T-DNA into the plant cell. Additional T-DNA may be present.
Das derartig transformierte Agrobakterium wird zur Transfor¬ mation von Pflanzenzellen verwendet.The agrobacterium transformed in this way is used for the transformation of plant cells.
Die Verwendung von T-DNA für die Transformation von Pflan¬ zenzellen ist intensiv untersucht und ausreichend in EP 120 515; Hoekema in: The Binary Plant Vector System, Offsetdrokkerij Kanters B.V., Alblasserdam (1985) Chapter V; Fraley et al . (1993) Crit . Rev. Plant. Sei. 4, 1-46 und An et al. (1985) EMBO J. 4, 277-287 beschrieben worden. Für den Transfer der DNA in die Pflanzenzelle können Pflan- zenexplantate zweckmäßigerweise mit Agrobacterium tumefa¬ ciens oder Agrobacterium rhizogenes kultiviert werden. Aus dem infizierten Pflanzenmaterial (z.B. Blattstücke, Stengel- Segmente, Wurzeln, aber auch Protoplasten oder Suspensions- kultivierte Pflanzenzellen) können dann in einem geeigneten Medium, welches Antibiotika oder Biozide zur Selektion transformierter Zellen enthalten kann, wieder ganze Pflanzen regeneriert werden. Die Regeneration der Pflanzen erfolgt nach üblichen Regenerationsmethoden unter Verwendung bekann¬ ter Nährmedien. Die so erhaltenen Pflanzen können dann auf Anwesenheit der eingeführten DNA untersucht werden. Andere Möglichkeiten der Einführung fremder DNA unter Verwendung des biolostischen Verfahrens oder durch Protoplasten-Trans¬ formation sind bekannt (vgl. z.B. Willmitzer L. (1993) Transgenic Plants, in: Biotechnology, A Multi-Volume Comprehensive Treatise (H.J. Rehm, G. Reed, A. Pühler, P. Stadler, eds . , Vol. 2, 627-659, V.C.H. Weinheim - New York - Basel - Cambridge) .The use of T-DNA for the transformation of plant cells has been intensively investigated and is sufficient in EP 120 515; Hoekema in: The Binary Plant Vector System, Offsetdrokkerij Kanters BV, Alblasserdam (1985) Chapter V; Fraley et al. (1993) Crit. Rev. Plant. Be. 4, 1-46 and An et al. (1985) EMBO J. 4, 277-287. For the transfer of the DNA into the plant cell, plant explants can expediently be cultivated with Agrobacterium tumefaciens or Agrobacterium rhizogenes. From the infected plant material (e.g. leaf pieces, stem Segments, roots, but also protoplasts or suspension-cultivated plant cells) can then regenerate whole plants again in a suitable medium, which can contain antibiotics or biocides for the selection of transformed cells. The plants are regenerated by customary regeneration methods using known nutrient media. The plants thus obtained can then be examined for the presence of the introduced DNA. Other possibilities of introducing foreign DNA using the biolostic method or by means of protoplast transformation are known (cf., for example, Willmitzer L. (1993) Transgenic Plants, in: Biotechnology, A Multi-Volume Comprehensive Treatise (HJ Rehm, G. Reed , A. Pühler, P. Stadler, eds., Vol. 2, 627-659, VCH Weinheim - New York - Basel - Cambridge).
Während die Transformation dikotyler Pflanzen über Ti-Plas- mid-Vektorsysteme mit Hilfe von Agrobacterium tumefaciens wohl etabliert ist, weisen neuere Arbeiten darauf hin, daß auch monokotyle Pflanzen der Agrobakterien-vermittelten Transformation mittels Agrobacterium-basierender Vektoren sehr wohl zugänglich sind (Chan et al. (1993) Plant Mol. Biol. 22, 491-506; Hiei et al . (1994) Plant J. 6, 271-282; Deng et al . (1990) Science in China 33, 28-34; Wilmink et al. (1992) Plant Cell Reports 11, 76-80; May et al . (1995) Bio/Technology 13, 486-492; Conner und Domiss (1992) Int. J. Plant Sei. 153, 550-555; Ritchie et al . (1993) Transgenic Res. 2, 252-265) .While the transformation of dicotyledonous plants via Ti plasmid vector systems with the help of Agrobacterium tumefaciens is well established, recent work indicates that monocotyledonous plants are also very well amenable to Agrobacterium-mediated transformation using Agrobacterium-based vectors (Chan et al . (1993) Plant Mol. Biol. 22, 491-506; Hiei et al. (1994) Plant J. 6, 271-282; Deng et al. (1990) Science in China 33, 28-34; Wilmink et al . (1992) Plant Cell Reports 11, 76-80; May et al. (1995) Bio / Technology 13, 486-492; Conner and Domiss (1992) Int. J. Plant Sei. 153, 550-555; Ritchie et al. (1993) Transgenic Res. 2, 252-265).
Alternative Systeme zur Tansformation von monokotylen Pflan¬ zen sind die Transformationen mittels des biolistischen An¬ satzes (Wan und Lemaux (1994) Plant Physiol. 104, 37-48; Vasil et al . (1993) Bio/Technology 11, 1553-1558; Ritala et al. (1994) Plant Mol. Biol. 24, 317-325; Spencer et al . (1990) Theor. Appl . Genet. 79, 625-631) , die Protoplasten- Transformation, die Elektroporation von partiell permeabili- sierten Zellen, die Einbringung von DNA mittels Glasfasern. Spezifisch die Transformation von Mais wird in der Literatur verschiedentlich beschrieben (vgl. z.B. WO 95/06128; EP 0 513 849; EP 0 465 875; Fromm et al. (1990) Biotechnology 8, 833-844; Gordon-Kamm et al . (1990) Plant Cell 2, 603-618; Koziel et al . (1993) Biotechnology 11, 194-200) . In EP 292 435 wird ein Verfahren beschrieben, mit Hilfe dessen, ausge¬ hend von einem schleimlosen, weichen (friable) granulösen Mais-Kallus, fertile Pflanzen erhalten werden können. Shillito et al . ( (1989) Bio/Technology 7; 581) haben in die¬ sem Zusammenhang beobachtet, daß es ferner für die Regene- rierbarkeit zu fertilen Pflanzen notwendig ist, von Kallus- Suspensionskulturen auszugehen, aus denen eine sich teilende Protoplastenkultur mit der Fähigkeit zu Pflanzen zu regene¬ rieren, herstellbar ist. Nach einer in vitro Kultivierungs- zeit von sieben bis acht Monaten erhalten Shillito et al . Pflanzen mit lebensfähigen Nachkommen, die jedoch Abnormali- täten in der Morphologie und der Reproduktion aufweisen. Prioli und Söndahl ((1989) Bio/Technology 7, 589) beschrei¬ ben die Regeneration und die Gewinnung fertiler Pflanzen aus Mais-Protoplasten, der Cateto-Mais-Inzuchtlinie Cat 100-1. Die Autoren vermuten, daß die Protoplasten-Regeneration zu fertilen Pflanzen von einer Anzahl verschiedener Faktoren, wie z.B. vom Genotyp, vom physiologischen Zustand der Donor- Zellen und von den Kultivierungsbedingungen, abhängig ist. Auch die erfolgreiche Transformation anderer Getreidearten wurde bereits beschrieben, z.B. für Gerste (Wan und Lemaux, a.a.O.; Ritala et al. , a.a.O.) und für Weizen (Nehra et al. (1994) Plant J. 5, 285-297) .Zen Alternative systems for Tansformation of monocotyledonous Pflan ¬ are the transformation by means of the biolistic An¬ set (Wan and Lemaux (1994) Plant Physiol 104, 37-48;. Vasil et al (1993) Bio / Technology 11, 1553-1558.; Ritala et al. (1994) Plant Mol. Biol. 24, 317-325; Spencer et al. (1990) Theor. Appl. Genet. 79, 625-631), the protoplast transformation, the electroporation of partially permeabilized Cells, the introduction of DNA using glass fibers. The transformation of maize is described in various ways in the literature (see, for example, WO 95/06128; EP 0 513 849; EP 0 465 875; Fromm et al. (1990) Biotechnology 8, 833-844; Gordon-Kamm et al. (1990) Plant Cell 2, 603-618; Koziel et al. (1993) Biotechnology 11, 194-200). EP 292 435 describes a process by means of which fertile plants can be obtained starting from a slimy, soft (friable) granular corn callus. Shillito et al. ((1989) Bio / Technology 7; 581) have observed in this connection that it is also necessary, in order to be able to regenerate into fertile plants, to start from callus suspension cultures from which a dividing protoplast culture with the ability to plants to regenerate, is producible. After an in vitro cultivation period of seven to eight months, Shillito et al. Plants with viable offspring that, however, have abnormalities in morphology and reproduction. Prioli and Sondahl ((1989) Bio / Technology 7, 589) describe the regeneration and the production of fertile plants from maize protoplasts, the Cateto maize inbred line Cat 100-1. The authors suspect that protoplast regeneration to fertile plants depends on a number of different factors, such as, for example, the genotype, the physiological state of the donor cells and the cultivation conditions. The successful transformation of other cereals has also been described, for example for barley (Wan and Lemaux, loc. Cit., Ritala et al., Loc. Cit.) And for wheat (Nehra et al. (1994) Plant J. 5, 285-297).
Ist die eingeführte DNA einmal im Genom der Pflanzenzelle integriert, so ist sie dort in der Regel stabil und bleibt auch in den Nachkommen der ursprünglich transformierten Zelle erhalten. Sie enthält normalerweise einen Selektions- marker, der den transformierten Pflanzenzellen Resistenz ge¬ genüber einem Biozid oder einem Antibiotikum wie Kanamycin, G418, Bleomycin, Hygromycin, Methotrexat, Glyphosat, Strep- tomycin, Sulfonyl-Harnstoff, Gentamycin oder Phosphinotricin u.a. vermittelt. Der individuell gewählte Marker sollte da¬ her die Selektion transformierter Zellen gegenüber Zellen, denen die eingeführte DNA fehlt, gestatten. Die transformierten Zellen wachsen innerhalb der Pflanze in der üblichen Weise (siehe auch McCormick et al . (1986) Plant Cell Reports 5, 81-84) . Die resultierenden Pflanzen können normal angezogen werden und mit Pflanzen, die die gleiche transformierte Erbanlage oder andere Erbanlagen besitzen, gekreuzt werden. Die daraus entstehenden hybriden Individuen haben die entsprechenden phänotypischen Eigenschaften. Von den Pflanzen können Samen gewonnen werden.Once the introduced DNA is integrated in the genome of the plant cell, it is generally stable there and is also retained in the progeny of the originally transformed cell. It normally contains a selection marker which imparts resistance to the transformed plant cells to a biocide or an antibiotic such as kanamycin, G418, bleomycin, hygromycin, methotrexate, glyphosate, streptomycin, sulfonylurea, gentamycin or phosphinotricin and others. The individually selected marker should therefore allow the selection of transformed cells over cells that lack the inserted DNA. The transformed cells grow within the plant in the usual way (see also McCormick et al. (1986) Plant Cell Reports 5, 81-84). The resulting plants can be grown normally and crossed with plants that have the same transformed genetic makeup or other genetic makeup. The resulting hybrid individuals have the corresponding phenotypic properties. Seeds can be obtained from the plants.
Es sollten zwei oder mehrere Generationen angezogen werden, um sicherzustellen, daß das phänotypische Merkmal stabil beibehalten und vererbt wird. Auch sollten Samen geerntet werden, um sicherzustellen, daß der entsprechende Phänotyp oder andere Eigenarten erhalten geblieben sind. Ebenso können nach üblichen Methoden transgene Linien be¬ stimmt werden, die für die neuen Nucleinsäuremoleküle homo- zygot sind und ihr phänotypisches Verhalten hinsichtlich ei¬ nes lokalisierten Zelltods und/oder einer SAR und/oder er¬ höhter Krankheitsresistenz und/oder männlicher Sterilität untersucht und mit dem von hemizygoten Linien verglichen werden. Figur 1: zeigt das Auftreten nekrotischer Bereiche in transgenen Tabakpflanzen, die mit dem KonstruktTwo or more generations should be grown to ensure that the phenotypic trait is stably maintained and inherited. Seeds should also be harvested to ensure that the appropriate phenotype or other characteristics have been preserved. Likewise, transgenic lines can be determined by conventional methods, which are homozygous for the new nucleic acid molecules and which investigate and investigate their phenotypic behavior with regard to localized cell death and / or SAR and / or increased disease resistance and / or male sterility with that of hemizygote lines. Figure 1: shows the appearance of necrotic areas in transgenic tobacco plants with the construct
Lss8 transformiert worden sind.Lss8 have been transformed.
Figur 2: zeigt die Menge an Salicylsäure in transgenen Ta¬ bakpflanzen (1-5) im Vergleich zu Wildtyp-Pflanzen (6-7) .Figure 2: shows the amount of salicylic acid in transgenic tobacco plants (1-5) compared to wild-type plants (6-7).
Figur 3: zeigt das Ergebnis eines Northern Blot-Experi- ments. Zur Analyse wurden jeweils 30 μg poly(A)+- mRNA aus verschiedenen transgenen Tabakpflanzen (Spur 1-5) und zwei nicht-transformierten Tabak¬ pflanzen (Spur 6-7) verwendet. Als Sonde wurde eine cDNA des PR-1-l-Gens verwendet. 23Figure 3: shows the result of a Northern blot experiment. 30 μg poly (A) + mRNA from different transgenic tobacco plants (lane 1-5) and two non-transformed tobacco plants (lane 6-7) were used for the analysis. A cDNA of the PR-1 l gene was used as a probe. 23
Die nachfolgenden Beispiele dienen der Erläuterung der Er¬ findung.The following examples serve to explain the invention.
In den Beispielen werden die folgenden Methoden verwendet:The following methods are used in the examples:
1. Clonierungsverfahren:1. Cloning procedure:
Für die Clonierung in E. coli wurde der Vektor pBluescript II SK (Stratagene) verwendet.The vector pBluescript II SK (Stratagene) was used for cloning in E. coli.
2. Bakterienstämme:2. Bacterial strains:
Für den Bluescript-Vektor und die Lss8-Konstrukte wurde der E. coli-Stamm DH5alpha (Bethesda Research Laboratories, Gaithersburgh, USA) verwendet.E. coli strain DH5alpha (Bethesda Research Laboratories, Gaithersburgh, USA) was used for the Bluescript vector and the Lss8 constructs.
3. Transformation von Kartoffeln:3. Transformation of potatoes:
Zehn kleine, mit dem Skalpell verwundete Blätter einer Kartoffelsterilkultur (Solanum tuberosum L. cv. Desiree) wurden in 10 ml MS-Medium (Murashige und Skoog (1962) Physiol. Plant. 15, 473) mit 2 % Saccharose gelegt, wel¬ ches 50 μl einer unter Selektion gewachsenen Agrobacte¬ rium tumefaciens-Übernachtkultur enthielt. Nach 3-5- minütigem, leichtem Schütteln erfolgte eine weitere In¬ kubation für zwei Tage im Dunkeln. Daraufhin wurden die Blätter zur Kallus-Induktion auf MS-Medium mit 1,6 % Glucose, 5 mg/1 Naphthylessigsäure, 0,2 mg/1 Benzylami- nopurin, 250 mg/1 Claforan, 50 mg/1 Kanamycin und 0,8 % Bacto-Agar gelegt. Nach einwöchiger Inkubation bei 25°C und 3000 Lux wurden die Blätter zur Sproßinduktion auf MS-Medium mit 1,6 % Glucose, 1,4 mg/1 Zeatinribose, 20 μg/1 Naphthylessigsäure, 20 μg/1 Giberellinsäure, 250 mg/1 Claforan, 50 mg/1 Kanamycin und 0,8 % Bacto-Agar gelegt.Ten small leaves of a potato sterile culture (Solanum tuberosum L. cv. Desiree) wounded with the scalpel were placed in 10 ml of MS medium (Murashige and Skoog (1962) Physiol. Plant. 15, 473) with 2% sucrose, which Contained 50 μl of an Agrobacte¬ rium tumefaciens overnight culture grown under selection. After shaking gently for 3-5 minutes, a further incubation was carried out for two days in the dark. The leaves were then used for callus induction on MS medium with 1.6% glucose, 5 mg / 1 naphthylacetic acid, 0.2 mg / 1 benzylaminopurine, 250 mg / 1 claforan, 50 mg / 1 kanamycin and 0.8 % Bacto agar placed. After incubation for one week at 25 ° C. and 3000 lux, the leaves were induction on MS medium with 1.6% glucose, 1.4 mg / 1 zeatin ribose, 20 μg / 1 naphthylacetic acid, 20 μg / 1 giberellic acid, 250 mg / 1 Claforan, 50 mg / 1 kanamycin and 0.8% Bacto agar.
4. Transformation von Tabakpflanzen und Regeneration intak¬ ter Pflanzen:4. Transformation of tobacco plants and regeneration of intact plants:
Eine Übernachtkultur des entsprechenden Agrobacterium tumefaciens-Clons wurde für drei Minuten bei 6500 rpm abzentrifugiert, und die Bakterien wurden in YEB-Medium resuspendiert . Tabakblätter einer Tabaksterilkultur (Nicotiana Tabacum cv. Samsun NN) wurden in kleine, ca. 1 cm2 große Stücke zerschnitten und in der Bakteriensus- pension gebadet. Die Blattstücke wurden anschließend auf MS-Medium (0,7 % Agar) gelegt und zwei Tage im Dunkeln inkubiert. Anschließend wurden die Blattstücke zur Sproßinduktion auf MS-Medium (0,7 % Agar) mit 1,6 % Glu¬ cose, 1 mg/1 6-Benzylaminopurin, 0,2 mg/1 Naphthylessig¬ säure, 500 mg/1 Claforan und 50 mg/1 Kanamycin gelegt. Das Medium wurde alle sieben bis 10 Tage gewechselt. Wenn sich Sprosse entwickelt hatten, wurden die Blatt¬ stücke in Glasgefäße, die dasselbe Medium enthielten, überführt. Entstehende Sprosse wurden abgeschnitten und auf MS-Medium mit 2 % Saccharose und 250 mg/1 Claforan gegeben und aus ihnen ganze Pflanzen regeneriert.An overnight culture of the corresponding Agrobacterium tumefaciens clone was carried out at 6500 rpm for three minutes centrifuged and the bacteria were resuspended in YEB medium. Tobacco leaves from a tobacco sterile culture (Nicotiana Tabacum cv. Samsun NN) were cut into small pieces measuring approx. 1 cm 2 and bathed in the bacterial suspension. The leaf pieces were then placed on MS medium (0.7% agar) and incubated for two days in the dark. Then the leaf pieces for shoot induction on MS medium (0.7% agar) with 1.6% glucose, 1 mg / 1 6-benzylaminopurine, 0.2 mg / 1 naphthylacetic acid, 500 mg / 1 claforan and 50 mg / 1 kanamycin. The medium was changed every seven to ten days. When shoots had developed, the leaf pieces were transferred to glass vessels which contained the same medium. Resulting shoots were cut off and placed on MS medium with 2% sucrose and 250 mg / 1 Claforan and whole plants were regenerated from them.
5. RNA-Extraktion und Northern Blot-Experimente : RNA wurde aus gefrorenem Pflanzenmaterial isoliert, wie beschrie¬ ben in Logemann et al . (1987) Anal. Biochem. 163, 21-26. Die RNA wurde in 40 % Formamid denaturiert. Anschließend wurde die .RNA gelelektrophoretisch auf Formalde- hyd/Agarose-Gelen aufgetrennt und nach dem Gellauf auf Nylonmembranen (Hybond N; Amersham, UK) geblottet . Die Hybridisierung gegen eine radioaktiv-markierte DNA-Sonde erfolgte nach Standardmethoden (z.B. Sambrook et al, a.a.O. ) .5. RNA extraction and Northern blot experiments: RNA was isolated from frozen plant material, as described in Logemann et al. (1987) Anal. Biochem. 163, 21-26. The RNA was denatured in 40% formamide. The .RNA was then separated by gel electrophoresis on formaldehyde / agarose gels and blotted on nylon membranes (Hybond N; Amersham, UK) after the gel run. Hybridization against a radioactively labeled DNA probe was carried out according to standard methods (e.g. Sambrook et al, op. Cit.).
6. Pflanzenhaltung:6. Plant husbandry:
Kartoffelpflanzen (Solanum tuberosum) wurden im Gewächs¬ haus bei 60 % Luftfeuchtigkeit und 22°C für 16 Stunden im Licht und 15°C für 8 Stunden in Dunkelheit gehalten. Tabakpflanzen (Nicotiana tabacum) wurden im Gewächshaus bei 60 % Luftfeuchtigkeit und 25°C für 14 Stunden im Licht und 20°C für 10 Stunden in Dunkelheit gehalten. 7. Bestimmung von Salicylsäuregehalten:Potato plants (Solanum tuberosum) were kept in the greenhouse ¬ house at 60% humidity and 22 ° C for 16 hours in the light and 15 ° C for 8 hours in darkness. Tobacco plants (Nicotiana tabacum) were kept in the greenhouse at 60% humidity and 25 ° C for 14 hours in the light and 20 ° C for 10 hours in the dark. 7. Determination of salicylic acid contents:
Zur Bestimmung des Gehaltes an Salicylsäure wurden die Methoden, wie bei Yalpani et al . (1991) The Plant Cell 3, 809-818 und Gaffney et al . (1993) Science 261, 754- 756 beschrieben, eingesetzt.To determine the salicylic acid content, the methods as described by Yalpani et al. (1991) The Plant Cell 3, 809-818 and Gaffney et al. (1993) Science 261, 754-756.
Beispiel 1example 1
Konstruktion eines Chimären Gens bestehend aus der codieren¬ den Region des Levansucrase-Gens aus Erwinia amylovora und einer verkürzten Promotorregion des prpl-1-Gens aus Solanum tuberosumConstruction of a chimeric gene consisting of the coding region of the levansucrase gene from Erwinia amylovora and a shortened promoter region of the prpl-1 gene from Solanum tuberosum
Zunächst wurde mit Hilfe der Restriktionsenzyme EcoRI und Xbal ein Fragment des prpl-1-Promotors, das die Nucleotide +31 bis -402 umfaßt, aus dem Plasmid pBS42-l (Martini et al . (1993) Mol. Gen. Genetics 236, 179-186) herausgeschnitten. Dieser EcoRI-Xbal-Promotorfragment wurde anschließend in den Vektor BINAR (Höfgen und Willmitzer (1992) Plant Science 87, 45-54) ligiert, wobei aus dem Vektor BINAR durch Verwendung der gleichen Enzyme der CaMV 35S-Promotor herausgeschnitten wurde. Der entstandene binäre Vektor enthält somit die prpl- 1-Promotorregion und das Terminationssignal des Octopinsyn- thase-Gens (OCS) getrennt durch Restriktionsschnittstellen des pUC18-Polylinkers, der das Einfügen codierender Regionen und somit die Konstruktion entsprechender Expressionskasset¬ ten erlaubt . Anschließend wurde die codierende Region der Levansucrase mit Hilfe der Restriktionsenzyme Xbal und Sall aus dem Vektor pEa-LSK5 (Geier und Geider (1993) Physiol. Mol. Plant Pathology 42, 387-404) herausgeschnitten und in den analog geschnittenen, das prpl-1-Promotorfragment ent¬ haltenden Vektor eingesetzt . Dieser als Lss8 bezeichnete Vektor wurde sodann in Agrobacterium tumefaciens transfor¬ miert und zur Transformation von Tabakpflanzen und Kartof¬ felpflanzen eingesetzt. Beispiel 2First, using the restriction enzymes EcoRI and Xbal, a fragment of the prpl-1 promoter, which encompasses nucleotides +31 to -402, was made from plasmid pBS42-1 (Martini et al. (1993) Mol. Gen. Genetics 236, 179 -186) cut out. This EcoRI-Xbal promoter fragment was then ligated into the vector BINAR (Höfgen and Willmitzer (1992) Plant Science 87, 45-54), the CaMV 35S promoter being excised from the vector BINAR using the same enzymes. The resulting binary vector thus contains the prpl-1 promoter region and the termination signal of the octopine synthase gene (OCS) separated by restriction sites of the pUC18 polylinker, which allows the insertion of coding regions and thus the construction of appropriate expression cassettes. The coding region of the levan sucrase was then cut out of the vector pEa-LSK5 (Geier and Geider (1993) Physiol. Mol. Plant Pathology 42, 387-404) using the restriction enzymes Xbal and Sall and the prpl-1 Vector containing promoter fragment. This vector, designated Lss8, was then transformed into Agrobacterium tumefaciens and used for the transformation of tobacco plants and potato plants. Example 2
Analyse transgener Tabak- und Kartoffelpflanzen, die den Vektor Lss8 enthaltenAnalysis of transgenic tobacco and potato plants that contain the vector Lss8
Transgene Tabak- und Kartoffelpflanzen wurden wie oben be¬ schrieben transformiert, selektioniert und regeneriert. Nach Bewurzelung m Steπlkultur wurden ca. 50 unabhängige Trans- formanten im Gewächshaus in Erde überfuhrt. 6 bis 8 Linien, die einen durch das Auftreten von nekrotischen Flecken ein¬ deutig gekennzeichneten Phänotyp aufwiesen, konnten identi¬ fiziert werden (siehe Figur 1) . Die Analyse dieser nekroti¬ schen Bereiche auf das Vorhandensein von Levan, nach der oben beschriebenen Methode, erbrachte eindeutig den Nachweis von Levan Diese Pflanzen, die Aufgrund der Expression des Chimären Genkonstrukts pLSS8 einen lokalisierten Zelltod aufwiesen, wurden sodann im Gewächshaus weiteren Analysen unterzogen.Transgenic tobacco and potato plants were transformed, selected and regenerated as described above. After rooting in stone culture, approx. 50 independent transformants were transferred to soil in the greenhouse. 6 to 8 lines which had a phenotype clearly identified by the appearance of necrotic spots could be identified (see FIG. 1). The analysis of these necrotic areas for the presence of Levan by the method described above clearly provided evidence of Levan. These plants, which had localized cell death due to the expression of the chimeric gene construct pLSS8, were then subjected to further analyzes in the greenhouse.
Beispiel 3Example 3
Bestimmung des SalicylsäuregehaltsDetermination of the salicylic acid content
Der Salicylsauregehalt verschiedener Transformanten wurde nach den oben angegebenen Methoden bestimmt . Wie aus Figur 2 ersichtlich ist, weisen die transgenen Tabakpflanzen, die sich durch einen lokalisierten Zelltod auszeichnen, eine um einen Faktor 2-8 höhere Salicylsäuremenge im Vergleich zu Wildtyp-Pflanzen auf.The salicylic acid content of various transformants was determined using the methods given above. As can be seen from Figure 2, the transgenic tobacco plants, which are characterized by localized cell death, have a 2-8 times higher amount of salicylic acid compared to wild-type plants.
Beispiel 4Example 4
Analyse der Expression von typischen PR-ProteinenAnalysis of the expression of typical PR proteins
Die systemisch erworbene Resistenz (SAR) ist durch die koor¬ dinierte Expression mehrerer Gene gekennzeichnet (Ward et al . (1991) The Plant Cell 3, 1085-1094) . Zu den Genprodukten dieser sogenannten SAR-Gene gehören die PR-Proteine (Patho- genesis-related proteins) (vgl. Van Loon (1985) Plant Mol. Biol. 4, 111-116) . Da ein Zusammenhang zwischen der Expres¬ sion der PR-Proteine und der Entstehung der SAR als gesi¬ chert gilt, kann die Expression typischer PR-Proteine als Indiz für die Entstehung bzw. das Vorhandensein einer SAR herangezogen werden. Die Expression von PR-Proteinen in Pflanzen, die das chimäre Lss8-Gen exprimieren, wurde mit¬ tels Northern Blot-Analyse untersucht. Wie in Figur 3 zu er¬ kennen ist, läßt sich sowohl in grünen als auch in den be¬ reits nekrotische Flecken aufweisenden Bereichen der Tabak¬ pflanzen, die Expression des homologen PRl-1-Gens nachwei¬ sen, während dies in nicht-transformierten Kontrollpflanzen nicht der Fall ist. Systemic acquired resistance (SAR) is defined by the coor ¬ ordinated expression of multiple genes in (Ward et al. (1991) The Plant Cell 3, 1085-1094). To the gene products these so-called SAR genes include the PR proteins (pathogenesis-related proteins) (cf. Van Loon (1985) Plant Mol. Biol. 4, 111-116). Since a relationship between the expression of the PR proteins and the formation of the SAR is considered to be secured, the expression of typical PR proteins can be used as an indication of the formation or the presence of a SAR. The expression of PR proteins in plants which express the chimeric Lss8 gene was examined by means of Northern blot analysis. As can be seen in FIG. 3, the expression of the homologous PRI-1 gene can be detected both in green and in areas of the tobacco plants which already have necrotic spots, while in non-transformed areas Control plants are not.

Claims

P a t e n t a n s p r ü c h e Patent claims
1. Nucleinsäuremolekül, bestehend aus den folgenden Be¬ standteilen, die in 5 ' -3 ' -Orientierung miteinander ver¬ knüpft sind:1. Nucleic acid molecule consisting of the following constituents which are linked to one another in a 5 '-3' orientation:
(a) einem in Pflanzen funktionsfähigen Promotor ausge¬ wählt aus:(a) a promoter which is functional in plants is selected from:
(i) einem pathogen-induzierten Promotor, oder (ii) einem in Pflanzen konstitutiv aktiven Promotor in Kombination mit einem transposablen Ele¬ ment, wobei das transposable Element den Pro¬ motor von der zu transkribierenden Nucleinsäu¬ resequenz trennt; und(i) a pathogen-induced promoter, or (ii) a promoter constitutively active in plants in combination with a transposable element, the transposable element separating the promoter from the nucleic acid sequence to be transcribed; and
(b) mindestens einer Nucleinsäuresequenz, die ein Pro¬ tein mit der enzymatischen Aktivität einer Levan¬ sucrase codiert .(b) at least one nucleic acid sequence which encodes a protein with the enzymatic activity of a levan sucrase.
2. Nucleinsäuremolekül nach Anspruch 1, wobei der Promotor der prpl-1-Promotor aus Solanum tuberosum ist.2. The nucleic acid molecule according to claim 1, wherein the promoter is the prpl-1 promoter from Solanum tuberosum.
3. Nucleinsäuremolekül nach Anspruch 1 oder 2, wobei die Nucleinsäuresequenz eine Levansucrase aus Erwinia amylovora codiert .3. Nucleic acid molecule according to claim 1 or 2, wherein the nucleic acid sequence encodes a levansucrase from Erwinia amylovora.
4. Nucleinsäuremolekül nach einem der Ansprüche 1 bis 3 , wobei die Nucleinsäuresequenz eine Sequenz umfaßt, die die Sekretion der Levansucrase gewährleistet.4. Nucleic acid molecule according to one of claims 1 to 3, wherein the nucleic acid sequence comprises a sequence which ensures the secretion of levan sucrase.
5. Nucleinsäuremolekül nach einem der Ansprüche 1 bis 4, das weiterhin ein Terminationssignal für die Termination der Transkription und die Addition eines poly-A-Schwan- zes an das entsprechende Transkript enthält, wobei die¬ ses hinter der unter (b) genannten Nucleinsäuresequenz angeordnet ist . 5. Nucleic acid molecule according to one of claims 1 to 4, which further contains a termination signal for the termination of the transcription and the addition of a poly-A tail to the corresponding transcript, the ¬ ses arranged behind the nucleic acid sequence mentioned under (b) is.
6. Nucleinsäuremolekül nach Anspruch 5, wobei das Termina¬ tionssignal jenes des Octopin-Synthase-Gens aus Agrobac¬ terium tumefaciens ist.6. Nucleic acid molecule according to claim 5, wherein the termination signal is that of the octopine synthase gene from Agrobacterium tumefaciens.
7. Nucleinsäuremolekül nach einem der Ansprüche 1 bis 5, das zusätzliche Enhancer-Sequenzen enthält.7. Nucleic acid molecule according to one of claims 1 to 5, which contains additional enhancer sequences.
8. Vektor enthaltend ein Nucleinsäuremolekül nach einem der Ansprüche 1 bis 7.8. vector containing a nucleic acid molecule according to any one of claims 1 to 7.
9. Wirtszelle enthaltend ein Nucleinsäuremolekül nach einem der Ansprüche 1 bis 7 oder einen Vektor nach Anspruch 8.9. host cell containing a nucleic acid molecule according to any one of claims 1 to 7 or a vector according to claim 8.
10. Transgene Pflanzenzelle, die genetisch modifiziert ist mit einem Nucleinsäuremolekül nach einem der Ansprüche 1 bis 7 oder mit einem Vektor nach Anspruch 8.10. Transgenic plant cell that is genetically modified with a nucleic acid molecule according to one of claims 1 to 7 or with a vector according to claim 8.
11. Pflanze enthaltend Pflanzenzellen nach Anspruch 10.11. Plant containing plant cells according to claim 10.
12. Pflanze nach Anspruch 11, die mindestens ein für eine systemisch erworbene Resistenz typisches Phänomen aus¬ prägt.12. Plant according to claim 11, which forms at least one phenomenon typical of a systemically acquired resistance.
13. Pflanze nach Anspruch 11 oder 12, die eine im Vergleich zu nicht transformierten Pflanzen erhöhte Salicylsäure- Konzentration aufweist .13. Plant according to claim 11 or 12, which has an increased salicylic acid concentration in comparison to non-transformed plants.
14. Pflanze nach einem der Ansprüche 11 bis 13, die im Ver¬ gleich zu nicht-transformierten Pflanzen eine erhöhte Krankheitsresistenz aufweisen.14. Plant according to one of claims 11 to 13, which have an increased disease resistance compared to non-transformed plants.
15. Verwendung einer Nucleinsäuresequenz, die ein Polypeptid mit der enzymatischen Aktivität einer Levansucrase co¬ diert, zur Erzeugung eines lokalisierten Zelltods bei Pflanzen. 15. Use of a nucleic acid sequence, which encodes a polypeptide with the enzymatic activity of a levan sucrase, for producing a localized cell death in plants.
16. Verwendung einer Nucleinsäuresequenz, die ein Polypeptid mit der enzymatischen Aktivität einer Levansucrase co¬ diert, zur Erzeugung einer systemisch erworbenen Resi¬ stenz bei Pflanzen.16. Use of a nucleic acid sequence which encodes a polypeptide with the enzymatic activity of a levan sucrase to generate a systemically acquired resistance in plants.
17. Verwendung einer Nucleinsäuresequenz, die ein Polypeptid mit der enzymatischen Aktivität einer Levansucrase co¬ diert, zur Erhöhung der Salicylsäure-Konzentration in Pflanzen.17. Use of a nucleic acid sequence, which encodes a polypeptide with the enzymatic activity of a levan sucrase, to increase the salicylic acid concentration in plants.
18. Verwendung einer Nucleinsäuresequenz, die ein Polypeptid mit der enzymatischen Aktivität einer Levansucrase co¬ diert, zur Erzeugung von Pflanzen mit erhöhter Krank¬ heitsresistenz . 18. Use of a nucleic acid sequence that encodes a polypeptide with the enzymatic activity of a levan sucrase for the production of plants with increased disease resistance.
PCT/EP1997/002749 1996-05-29 1997-05-27 Localised cell death in plants WO1997045547A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU31684/97A AU3168497A (en) 1996-05-29 1997-05-27 Localised cell death in plants

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19621572.2 1996-05-29
DE1996121572 DE19621572A1 (en) 1996-05-29 1996-05-29 Localized cell death in plants

Publications (2)

Publication Number Publication Date
WO1997045547A2 true WO1997045547A2 (en) 1997-12-04
WO1997045547A3 WO1997045547A3 (en) 1998-01-15

Family

ID=7795604

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP1997/002749 WO1997045547A2 (en) 1996-05-29 1997-05-27 Localised cell death in plants

Country Status (3)

Country Link
AU (1) AU3168497A (en)
DE (1) DE19621572A1 (en)
WO (1) WO1997045547A2 (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999043821A1 (en) * 1998-02-26 1999-09-02 Pioneer Hi-Bred International, Inc. Genes for activation of plant pathogen defense systems
EP0957672A1 (en) * 1996-12-05 1999-11-24 Cornell Research Foundation, Inc. Hypersensitive response induced resistance in plants by seed treatment
WO2000015817A2 (en) * 1998-09-17 2000-03-23 Pioneer Hi-Bred International, Inc. Stomatin-like genes and their use in plants

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6271439B1 (en) 1998-03-04 2001-08-07 Pioneer Hi-Bred International, Inc. Methods and compositions for regulating cell death and enhancing disease resistance to plant pathogens

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255378A2 (en) * 1986-07-31 1988-02-03 Calgene, Inc. Seed specific transcriptional regulation
EP0392225A2 (en) * 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
DE4227061A1 (en) * 1992-08-12 1994-02-17 Inst Genbiologische Forschung A polyfructane sucrase DNA sequence from Erwinia Amylovora
WO1995031564A2 (en) * 1994-05-11 1995-11-23 John Innes Centre Innovations Limited Method of introducing pathogen resistance in plants

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0292435B1 (en) * 1987-05-20 1995-07-26 Ciba-Geigy Ag Zea mays plants and transgenic zea mays plants regenerated from protoplasts or protoplast-derived cells
US7705215B1 (en) * 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
NL9000773A (en) * 1990-04-02 1991-11-01 Rijkslandbouwhogeschool PROCESS FOR PROTECTING PLANTS AGAINST PATHOGENS
DK0465875T3 (en) * 1990-06-23 1999-08-09 Hoechst Schering Agrevo Gmbh Process for producing a callus culture of Zea mays (L.)
ATE381622T1 (en) * 1991-02-07 2008-01-15 Bayer Bioscience Nv STAMEN SPECIFIC PROMOTORS FROM CORN
ATE332381T1 (en) * 1991-02-08 2006-07-15 Bayer Bioscience Nv STAMEN SPECIFIC PROMOTORS FROM RICE
DE4417879A1 (en) * 1994-05-18 1995-11-23 Inst Genbiologische Forschung New DNA sequence encoding amylo:sucrase of Neisseria

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0255378A2 (en) * 1986-07-31 1988-02-03 Calgene, Inc. Seed specific transcriptional regulation
EP0392225A2 (en) * 1989-03-24 1990-10-17 Ciba-Geigy Ag Disease-resistant transgenic plants
DE4227061A1 (en) * 1992-08-12 1994-02-17 Inst Genbiologische Forschung A polyfructane sucrase DNA sequence from Erwinia Amylovora
WO1995031564A2 (en) * 1994-05-11 1995-11-23 John Innes Centre Innovations Limited Method of introducing pathogen resistance in plants

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
G. GEIER AND K. GEIDER: "Characterization and influence on virulence of the levansucrase gene from the fireblight pathogen Erwinia amylovora" PHYSIOLOGICAL AND MOLECULAR PLANT PATHOLOGY, Bd. 42, 1993, LONDON, GB, Seiten 387-404, XP002044933 in der Anmeldung erw{hnt *
N. MARTINI ET AL.,: "Promoter sequences of a potato pathogenesis-related gene mediate transcriptional activation selectively upon fungal infection" MOLECULAR & GENERAL GENETICS, Bd. 236, 1993, BERLIN, DE, Seiten 179-186, XP002044934 in der Anmeldung erw{hnt *
R. HOFGEN AND L. WILLMITZER: "Transgenic potato plants depleted for the major tuber protein patatin via expression of antisense RNA" PLANT SCIENCE, Bd. 87, 1992, AMSTERDAM, NL, Seiten 45-54, XP002044935 in der Anmeldung erw{hnt *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0957672A1 (en) * 1996-12-05 1999-11-24 Cornell Research Foundation, Inc. Hypersensitive response induced resistance in plants by seed treatment
EP0957672A4 (en) * 1996-12-05 2005-01-26 Cornell Res Foundation Inc Hypersensitive response induced resistance in plants by seed treatment
WO1999043821A1 (en) * 1998-02-26 1999-09-02 Pioneer Hi-Bred International, Inc. Genes for activation of plant pathogen defense systems
WO2000015817A2 (en) * 1998-09-17 2000-03-23 Pioneer Hi-Bred International, Inc. Stomatin-like genes and their use in plants
WO2000015817A3 (en) * 1998-09-17 2000-06-08 Pioneer Hi Bred Int Stomatin-like genes and their use in plants

Also Published As

Publication number Publication date
DE19621572A1 (en) 1997-12-04
WO1997045547A3 (en) 1998-01-15
AU3168497A (en) 1998-01-05

Similar Documents

Publication Publication Date Title
DE69929073T2 (en) Methods and compositions for the transformation of plants
DE60017781T2 (en) MODULATION OF THE RESPONSE OF A PLANT ON ABSCISIN ACID
DE69933713T2 (en) Corn alpha-tubulin 3-18 promoter
DE69535563T2 (en) TRANSGENIC PLANTS EXPRESSING DNA CONSTRUCTS CONTAINING SEVERAL VIRUS RESISTANT GENES
DE602004004070T2 (en) USE OF THE REGULATORY SEQUENCE OF THE GOS2 GENE FROM RICE FOR GENE EXPRESSION IN DIKOTYLEDONES PLANTS OR PLANT CELLS
DE69928264T2 (en) SEED FAVORITE PROMOTERS
DE4004800C2 (en) Transgenic plants changed in habit and yield
DE60216116T2 (en) Vascular tissue specific promoters
EP0375091A1 (en) Wound-inducible and potato tuber-specific transcriptional regulation
JPH07506485A (en) Fungus-responsive chimeric gene
EP0462065B1 (en) New signal sequences
DE69731655T2 (en) PROTEINS PROVIDED AGAINST FUNGI, DAFUER ENCODING DNA AND ORGANISMS THAT INCLUDE THESE
EP0418695A1 (en) Regulatory DNA sequence
DE60035892T2 (en) GENES AND METHOD FOR GROWTH MANIPULATION
DE69633568T2 (en) EXPRESSION CONTROL SEQUENCE FOR GENERAL AND EFFECTIVE GENE EXPRESSION IN PLANTS
DE69433238T2 (en) PLANT PROMOTER, MICROORGANISMS AND PLANT CELLS WITH AN EXPRESSION UNIT FOR A DESIRED PROTEIN CONTAINING SUCH PROMOTER
DE69332148T2 (en) USE OF A DNA SEQUENCE, ENCODING FOR A PROTEIN WITH THE ABILITY TO DEGRADE OXALIC ACID, FOR GENESELECTION
DE60131075T2 (en) CONSTRUCTED BY RELEASE IN CLOSED, CIRCULAR FORM FROM A LARGER NUCLEOTIDE SEQUENCE WHICH ALLOWS THE SITE-SPECIFIC AND / OR DEVELOPMENT-SPECIFIC, REGULATED EXPRESSION OF SELECTED GENETIC SEQUENCES
EP2487245A2 (en) Method for increasing pathogen resistance in transgenic plants
DE3751099T2 (en) Virus-resistant plants with a viral coating protein.
WO1997045547A2 (en) Localised cell death in plants
EP0789773A1 (en) Processes for modifying plant flowering behaviour
EP0492536A2 (en) Method for the production of pathogen resistant plants
EP0428881A1 (en) RNA with endonuclease and antisense activity, its production and use
WO2006097465A2 (en) Method for increasing a fungal resistance of transgenic plants by a host induced suppression of a pathogenic fungi genetic expression

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AU CA CN IL JP US

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

AK Designated states

Kind code of ref document: A3

Designated state(s): AU CA CN IL JP US

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
NENP Non-entry into the national phase in:

Ref country code: JP

Ref document number: 97541606

Format of ref document f/p: F

NENP Non-entry into the national phase in:

Ref country code: CA

122 Ep: pct application non-entry in european phase